KR102223091B1 - Cosmetic composition for skin whitening comprising lignin peroxidase and decolorizing method of melanin in skin using the same - Google Patents
Cosmetic composition for skin whitening comprising lignin peroxidase and decolorizing method of melanin in skin using the same Download PDFInfo
- Publication number
- KR102223091B1 KR102223091B1 KR1020190060228A KR20190060228A KR102223091B1 KR 102223091 B1 KR102223091 B1 KR 102223091B1 KR 1020190060228 A KR1020190060228 A KR 1020190060228A KR 20190060228 A KR20190060228 A KR 20190060228A KR 102223091 B1 KR102223091 B1 KR 102223091B1
- Authority
- KR
- South Korea
- Prior art keywords
- melanin
- skin
- ala
- gly
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 title claims abstract description 230
- 239000000203 mixture Substances 0.000 title claims abstract description 67
- 108010054320 Lignin peroxidase Proteins 0.000 title claims abstract description 58
- 239000002537 cosmetic Substances 0.000 title claims abstract description 32
- 238000000034 method Methods 0.000 title claims abstract description 32
- 230000002087 whitening effect Effects 0.000 title claims abstract description 26
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims abstract description 79
- 239000004366 Glucose oxidase Substances 0.000 claims abstract description 46
- 108010015776 Glucose oxidase Proteins 0.000 claims abstract description 46
- 229940116332 glucose oxidase Drugs 0.000 claims abstract description 46
- 235000019420 glucose oxidase Nutrition 0.000 claims abstract description 46
- 238000004042 decolorization Methods 0.000 claims abstract description 38
- OEGPRYNGFWGMMV-UHFFFAOYSA-N (3,4-dimethoxyphenyl)methanol Chemical compound COC1=CC=C(CO)C=C1OC OEGPRYNGFWGMMV-UHFFFAOYSA-N 0.000 claims description 58
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 21
- 239000008103 glucose Substances 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 108090000623 proteins and genes Proteins 0.000 claims description 11
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 6
- 239000001301 oxygen Substances 0.000 claims description 6
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- 230000035614 depigmentation Effects 0.000 claims description 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- 238000004061 bleaching Methods 0.000 abstract description 29
- 230000000694 effects Effects 0.000 abstract description 27
- 210000003491 skin Anatomy 0.000 description 38
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 21
- 102000004190 Enzymes Human genes 0.000 description 20
- 108090000790 Enzymes Proteins 0.000 description 20
- 229940088598 enzyme Drugs 0.000 description 20
- 238000006243 chemical reaction Methods 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 150000001413 amino acids Chemical class 0.000 description 8
- 239000000872 buffer Substances 0.000 description 8
- 238000010586 diagram Methods 0.000 description 7
- -1 veratryl alcohol cation Chemical class 0.000 description 7
- 239000002202 Polyethylene glycol Substances 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- 229920001223 polyethylene glycol Polymers 0.000 description 6
- 238000001243 protein synthesis Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 239000007921 spray Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 230000014616 translation Effects 0.000 description 6
- 108010044467 Isoenzymes Proteins 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 239000000049 pigment Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 241000222393 Phanerochaete chrysosporium Species 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 125000006239 protecting group Chemical group 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 241000228245 Aspergillus niger Species 0.000 description 3
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- WUGMRIBZSVSJNP-UHFFFAOYSA-N N-L-alanyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C)C(O)=O)=CNC2=C1 WUGMRIBZSVSJNP-UHFFFAOYSA-N 0.000 description 3
- 102000003425 Tyrosinase Human genes 0.000 description 3
- 108060008724 Tyrosinase Proteins 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 2
- GMPWPTYBCCEVKH-UHFFFAOYSA-N 1,2-bis(3,4-dimethoxyphenyl)ethane-1,2-dione Chemical group C1=C(OC)C(OC)=CC=C1C(=O)C(=O)C1=CC=C(OC)C(OC)=C1 GMPWPTYBCCEVKH-UHFFFAOYSA-N 0.000 description 2
- HHGYNJRJIINWAK-FXQIFTODSA-N Ala-Ala-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N HHGYNJRJIINWAK-FXQIFTODSA-N 0.000 description 2
- RLMISHABBKUNFO-WHFBIAKZSA-N Ala-Ala-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O RLMISHABBKUNFO-WHFBIAKZSA-N 0.000 description 2
- CBWCQCANJSGUOH-ZKWXMUAHSA-N Asn-Val-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O CBWCQCANJSGUOH-ZKWXMUAHSA-N 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- DLISPGXMKZTWQG-IFFSRLJSSA-N Glu-Thr-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O DLISPGXMKZTWQG-IFFSRLJSSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- NTXIJPDAHXSHNL-ONGXEEELSA-N His-Gly-Val Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O NTXIJPDAHXSHNL-ONGXEEELSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LZDNBBYBDGBADK-UHFFFAOYSA-N L-valyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C(C)C)C(O)=O)=CNC2=C1 LZDNBBYBDGBADK-UHFFFAOYSA-N 0.000 description 2
- UCBPDSYUVAAHCD-UWVGGRQHSA-N Leu-Pro-Gly Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O UCBPDSYUVAAHCD-UWVGGRQHSA-N 0.000 description 2
- 108010059896 Manganese peroxidase Proteins 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 108010066427 N-valyltryptophan Proteins 0.000 description 2
- OJUMUUXGSXUZJZ-SRVKXCTJSA-N Phe-Asp-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O OJUMUUXGSXUZJZ-SRVKXCTJSA-N 0.000 description 2
- MLQVJYMFASXBGZ-IHRRRGAJSA-N Pro-Asn-Tyr Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O MLQVJYMFASXBGZ-IHRRRGAJSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- AUMNPAUHKUNHHN-BYULHYEWSA-N Val-Asn-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N AUMNPAUHKUNHHN-BYULHYEWSA-N 0.000 description 2
- VXDSPJJQUQDCKH-UKJIMTQDSA-N Val-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N VXDSPJJQUQDCKH-UKJIMTQDSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 108010044940 alanylglutamine Proteins 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 108010093581 aspartyl-proline Proteins 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 2
- 229950006191 gluconic acid Drugs 0.000 description 2
- 235000012208 gluconic acid Nutrition 0.000 description 2
- 108010078144 glutaminyl-glycine Proteins 0.000 description 2
- 108010089804 glycyl-threonine Proteins 0.000 description 2
- 108010050848 glycylleucine Proteins 0.000 description 2
- 150000003278 haem Chemical class 0.000 description 2
- 230000000415 inactivating effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 108010031424 isoleucyl-prolyl-proline Proteins 0.000 description 2
- 108010044056 leucyl-phenylalanine Proteins 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 108010003700 lysyl aspartic acid Proteins 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 108091033319 polynucleotide Proteins 0.000 description 2
- 239000002157 polynucleotide Substances 0.000 description 2
- 102000040430 polynucleotide Human genes 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000007026 protein scission Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000000196 tragacanth Substances 0.000 description 2
- 235000010487 tragacanth Nutrition 0.000 description 2
- 229940116362 tragacanth Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- VIYKYVYAKVNDPS-HKGPVOKGSA-N (2s)-2-azanyl-3-[3,4-bis(oxidanyl)phenyl]propanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1.OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 VIYKYVYAKVNDPS-HKGPVOKGSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- SFUCGABQOMYVJW-UHFFFAOYSA-N 4-(4-Hydroxyphenyl)-2-butanol Chemical compound CC(O)CCC1=CC=C(O)C=C1 SFUCGABQOMYVJW-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- JBVSSSZFNTXJDX-YTLHQDLWSA-N Ala-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)N JBVSSSZFNTXJDX-YTLHQDLWSA-N 0.000 description 1
- JBGSZRYCXBPWGX-BQBZGAKWSA-N Ala-Arg-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CCCN=C(N)N JBGSZRYCXBPWGX-BQBZGAKWSA-N 0.000 description 1
- IMMKUCQIKKXKNP-DCAQKATOSA-N Ala-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CCCN=C(N)N IMMKUCQIKKXKNP-DCAQKATOSA-N 0.000 description 1
- WCBVQNZTOKJWJS-ACZMJKKPSA-N Ala-Cys-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(O)=O WCBVQNZTOKJWJS-ACZMJKKPSA-N 0.000 description 1
- XYTNPQNAZREREP-XQXXSGGOSA-N Ala-Glu-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XYTNPQNAZREREP-XQXXSGGOSA-N 0.000 description 1
- WMYJZJRILUVVRG-WDSKDSINSA-N Ala-Gly-Gln Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(N)=O WMYJZJRILUVVRG-WDSKDSINSA-N 0.000 description 1
- BEMGNWZECGIJOI-WDSKDSINSA-N Ala-Gly-Glu Chemical compound [H]N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O BEMGNWZECGIJOI-WDSKDSINSA-N 0.000 description 1
- TZDNWXDLYFIFPT-BJDJZHNGSA-N Ala-Ile-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O TZDNWXDLYFIFPT-BJDJZHNGSA-N 0.000 description 1
- MLNSNVLOEIYJIU-ZUDIRPEPSA-N Ala-Leu-Thr-Gln Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O MLNSNVLOEIYJIU-ZUDIRPEPSA-N 0.000 description 1
- PIXQDIGKDNNOOV-GUBZILKMSA-N Ala-Lys-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O PIXQDIGKDNNOOV-GUBZILKMSA-N 0.000 description 1
- 108010011667 Ala-Phe-Ala Proteins 0.000 description 1
- XRUJOVRWNMBAAA-NHCYSSNCSA-N Ala-Phe-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 XRUJOVRWNMBAAA-NHCYSSNCSA-N 0.000 description 1
- IPZQNYYAYVRKKK-FXQIFTODSA-N Ala-Pro-Ala Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O IPZQNYYAYVRKKK-FXQIFTODSA-N 0.000 description 1
- VQAVBBCZFQAAED-FXQIFTODSA-N Ala-Pro-Asn Chemical compound C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)N)C(=O)O)N VQAVBBCZFQAAED-FXQIFTODSA-N 0.000 description 1
- FQNILRVJOJBFFC-FXQIFTODSA-N Ala-Pro-Asp Chemical compound C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)O)N FQNILRVJOJBFFC-FXQIFTODSA-N 0.000 description 1
- FEGOCLZUJUFCHP-CIUDSAMLSA-N Ala-Pro-Gln Chemical compound [H]N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O FEGOCLZUJUFCHP-CIUDSAMLSA-N 0.000 description 1
- OMCKWYSDUQBYCN-FXQIFTODSA-N Ala-Ser-Met Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(O)=O OMCKWYSDUQBYCN-FXQIFTODSA-N 0.000 description 1
- YCTIYBUTCKNOTI-UWJYBYFXSA-N Ala-Tyr-Asp Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N YCTIYBUTCKNOTI-UWJYBYFXSA-N 0.000 description 1
- VHAQSYHSDKERBS-XPUUQOCRSA-N Ala-Val-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O VHAQSYHSDKERBS-XPUUQOCRSA-N 0.000 description 1
- SGYSTDWPNPKJPP-GUBZILKMSA-N Arg-Ala-Arg Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SGYSTDWPNPKJPP-GUBZILKMSA-N 0.000 description 1
- QPOARHANPULOTM-GMOBBJLQSA-N Arg-Asn-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N QPOARHANPULOTM-GMOBBJLQSA-N 0.000 description 1
- ZZZWQALDSQQBEW-STQMWFEESA-N Arg-Gly-Tyr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZZZWQALDSQQBEW-STQMWFEESA-N 0.000 description 1
- NKNILFJYKKHBKE-WPRPVWTQSA-N Arg-Gly-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O NKNILFJYKKHBKE-WPRPVWTQSA-N 0.000 description 1
- GNYUVVJYGJFKHN-RVMXOQNASA-N Arg-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N GNYUVVJYGJFKHN-RVMXOQNASA-N 0.000 description 1
- HJDNZFIYILEIKR-OSUNSFLBSA-N Arg-Ile-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O HJDNZFIYILEIKR-OSUNSFLBSA-N 0.000 description 1
- ADPACBMPYWJJCE-FXQIFTODSA-N Arg-Ser-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O ADPACBMPYWJJCE-FXQIFTODSA-N 0.000 description 1
- FMYQECOAIFGQGU-CYDGBPFRSA-N Arg-Val-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FMYQECOAIFGQGU-CYDGBPFRSA-N 0.000 description 1
- YNDLOUMBVDVALC-ZLUOBGJFSA-N Asn-Ala-Ala Chemical compound C[C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CC(=O)N)N YNDLOUMBVDVALC-ZLUOBGJFSA-N 0.000 description 1
- ORXCYAFUCSTQGY-FXQIFTODSA-N Asn-Ala-Met Chemical compound C[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC(=O)N)N ORXCYAFUCSTQGY-FXQIFTODSA-N 0.000 description 1
- XWGJDUSDTRPQRK-ZLUOBGJFSA-N Asn-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O XWGJDUSDTRPQRK-ZLUOBGJFSA-N 0.000 description 1
- KUYKVGODHGHFDI-ACZMJKKPSA-N Asn-Gln-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O KUYKVGODHGHFDI-ACZMJKKPSA-N 0.000 description 1
- KLKHFFMNGWULBN-VKHMYHEASA-N Asn-Gly Chemical compound NC(=O)C[C@H](N)C(=O)NCC(O)=O KLKHFFMNGWULBN-VKHMYHEASA-N 0.000 description 1
- OLVIPTLKNSAYRJ-YUMQZZPRSA-N Asn-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)N OLVIPTLKNSAYRJ-YUMQZZPRSA-N 0.000 description 1
- SEKBHZJLARBNPB-GHCJXIJMSA-N Asn-Ile-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O SEKBHZJLARBNPB-GHCJXIJMSA-N 0.000 description 1
- HFPXZWPUVFVNLL-GUBZILKMSA-N Asn-Leu-Gln Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O HFPXZWPUVFVNLL-GUBZILKMSA-N 0.000 description 1
- JEEFEQCRXKPQHC-KKUMJFAQSA-N Asn-Leu-Phe Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JEEFEQCRXKPQHC-KKUMJFAQSA-N 0.000 description 1
- UXHYOWXTJLBEPG-GSSVUCPTSA-N Asn-Thr-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O UXHYOWXTJLBEPG-GSSVUCPTSA-N 0.000 description 1
- BIGRHVNFFJTHEB-UBHSHLNASA-N Asn-Trp-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(O)=O)C(O)=O BIGRHVNFFJTHEB-UBHSHLNASA-N 0.000 description 1
- QIRJQYQOIKBPBZ-IHRRRGAJSA-N Asn-Tyr-Arg Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QIRJQYQOIKBPBZ-IHRRRGAJSA-N 0.000 description 1
- WSWYMRLTJVKRCE-ZLUOBGJFSA-N Asp-Ala-Asp Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O WSWYMRLTJVKRCE-ZLUOBGJFSA-N 0.000 description 1
- NJIKKGUVGUBICV-ZLUOBGJFSA-N Asp-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O NJIKKGUVGUBICV-ZLUOBGJFSA-N 0.000 description 1
- TVVYVAUGRHNTGT-UGYAYLCHSA-N Asp-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(O)=O TVVYVAUGRHNTGT-UGYAYLCHSA-N 0.000 description 1
- VZNOVQKGJQJOCS-SRVKXCTJSA-N Asp-Asp-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O VZNOVQKGJQJOCS-SRVKXCTJSA-N 0.000 description 1
- PMEHKVHZQKJACS-PEFMBERDSA-N Asp-Gln-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O PMEHKVHZQKJACS-PEFMBERDSA-N 0.000 description 1
- ZSJFGGSPCCHMNE-LAEOZQHASA-N Asp-Gln-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)O)N ZSJFGGSPCCHMNE-LAEOZQHASA-N 0.000 description 1
- VILLWIDTHYPSLC-PEFMBERDSA-N Asp-Glu-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VILLWIDTHYPSLC-PEFMBERDSA-N 0.000 description 1
- PDECQIHABNQRHN-GUBZILKMSA-N Asp-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(O)=O PDECQIHABNQRHN-GUBZILKMSA-N 0.000 description 1
- SNDBKTFJWVEVPO-WHFBIAKZSA-N Asp-Gly-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(O)=O SNDBKTFJWVEVPO-WHFBIAKZSA-N 0.000 description 1
- RKNIUWSZIAUEPK-PBCZWWQYSA-N Asp-His-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC(=O)O)N)O RKNIUWSZIAUEPK-PBCZWWQYSA-N 0.000 description 1
- UJGRZQYSNYTCAX-SRVKXCTJSA-N Asp-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O UJGRZQYSNYTCAX-SRVKXCTJSA-N 0.000 description 1
- YRZIYQGXTSBRLT-AVGNSLFASA-N Asp-Phe-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O YRZIYQGXTSBRLT-AVGNSLFASA-N 0.000 description 1
- QJHOOKBAHRJPPX-QWRGUYRKSA-N Asp-Phe-Gly Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=CC=C1 QJHOOKBAHRJPPX-QWRGUYRKSA-N 0.000 description 1
- PCJOFZYFFMBZKC-PCBIJLKTSA-N Asp-Phe-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O PCJOFZYFFMBZKC-PCBIJLKTSA-N 0.000 description 1
- UAXIKORUDGGIGA-DCAQKATOSA-N Asp-Pro-Lys Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC(=O)O)N)C(=O)N[C@@H](CCCCN)C(=O)O UAXIKORUDGGIGA-DCAQKATOSA-N 0.000 description 1
- DRCOAZZDQRCGGP-GHCJXIJMSA-N Asp-Ser-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O DRCOAZZDQRCGGP-GHCJXIJMSA-N 0.000 description 1
- JJQGZGOEDSSHTE-FOHZUACHSA-N Asp-Thr-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O JJQGZGOEDSSHTE-FOHZUACHSA-N 0.000 description 1
- ITGFVUYOLWBPQW-KKHAAJSZSA-N Asp-Thr-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O ITGFVUYOLWBPQW-KKHAAJSZSA-N 0.000 description 1
- KACWACLNYLSVCA-VHWLVUOQSA-N Asp-Trp-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KACWACLNYLSVCA-VHWLVUOQSA-N 0.000 description 1
- XMKXONRMGJXCJV-LAEOZQHASA-N Asp-Val-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O XMKXONRMGJXCJV-LAEOZQHASA-N 0.000 description 1
- QOJJMJKTMKNFEF-ZKWXMUAHSA-N Asp-Val-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC(O)=O QOJJMJKTMKNFEF-ZKWXMUAHSA-N 0.000 description 1
- 241000123346 Chrysosporium Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- HYKFOHGZGLOCAY-ZLUOBGJFSA-N Cys-Cys-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(O)=O HYKFOHGZGLOCAY-ZLUOBGJFSA-N 0.000 description 1
- GUKYYUFHWYRMEU-WHFBIAKZSA-N Cys-Gly-Asp Chemical compound [H]N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O GUKYYUFHWYRMEU-WHFBIAKZSA-N 0.000 description 1
- SBDVXRYCOIEYNV-YUMQZZPRSA-N Cys-His-Gly Chemical compound C1=C(NC=N1)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CS)N SBDVXRYCOIEYNV-YUMQZZPRSA-N 0.000 description 1
- NITLUESFANGEIW-BQBZGAKWSA-N Cys-Pro-Gly Chemical compound [H]N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O NITLUESFANGEIW-BQBZGAKWSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 108010090461 DFG peptide Proteins 0.000 description 1
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 1
- 108030002463 Dye decolorizing peroxidases Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- YJIUYQKQBBQYHZ-ACZMJKKPSA-N Gln-Ala-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O YJIUYQKQBBQYHZ-ACZMJKKPSA-N 0.000 description 1
- DTCCMDYODDPHBG-ACZMJKKPSA-N Gln-Ala-Cys Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(O)=O DTCCMDYODDPHBG-ACZMJKKPSA-N 0.000 description 1
- RZSLYUUFFVHFRQ-FXQIFTODSA-N Gln-Ala-Glu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O RZSLYUUFFVHFRQ-FXQIFTODSA-N 0.000 description 1
- XOKGKOQWADCLFQ-GARJFASQSA-N Gln-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)N)N)C(=O)O XOKGKOQWADCLFQ-GARJFASQSA-N 0.000 description 1
- ZPDVKYLJTOFQJV-WDSKDSINSA-N Gln-Asn-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O ZPDVKYLJTOFQJV-WDSKDSINSA-N 0.000 description 1
- RKAQZCDMSUQTSS-FXQIFTODSA-N Gln-Asp-Gln Chemical compound C(CC(=O)N)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N RKAQZCDMSUQTSS-FXQIFTODSA-N 0.000 description 1
- JFSNBQJNDMXMQF-XHNCKOQMSA-N Gln-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)N)N)C(=O)O JFSNBQJNDMXMQF-XHNCKOQMSA-N 0.000 description 1
- ALUBSZXSNSPDQV-WDSKDSINSA-N Gln-Cys-Gly Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CS)C(=O)NCC(O)=O ALUBSZXSNSPDQV-WDSKDSINSA-N 0.000 description 1
- MFJAPSYJQJCQDN-BQBZGAKWSA-N Gln-Gly-Glu Chemical compound NC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O MFJAPSYJQJCQDN-BQBZGAKWSA-N 0.000 description 1
- FGYPOQPQTUNESW-IUCAKERBSA-N Gln-Gly-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)N FGYPOQPQTUNESW-IUCAKERBSA-N 0.000 description 1
- XSBGUANSZDGULP-IUCAKERBSA-N Gln-Gly-Lys Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCCCN)C(O)=O XSBGUANSZDGULP-IUCAKERBSA-N 0.000 description 1
- HYPVLWGNBIYTNA-GUBZILKMSA-N Gln-Leu-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O HYPVLWGNBIYTNA-GUBZILKMSA-N 0.000 description 1
- HWEINOMSWQSJDC-SRVKXCTJSA-N Gln-Leu-Arg Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O HWEINOMSWQSJDC-SRVKXCTJSA-N 0.000 description 1
- XZLLTYBONVKGLO-SDDRHHMPSA-N Gln-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)N)N)C(=O)O XZLLTYBONVKGLO-SDDRHHMPSA-N 0.000 description 1
- LHMWTCWZARHLPV-CIUDSAMLSA-N Gln-Met-Ser Chemical compound CSCC[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCC(=O)N)N LHMWTCWZARHLPV-CIUDSAMLSA-N 0.000 description 1
- FTTHLXOMDMLKKW-FHWLQOOXSA-N Gln-Phe-Phe Chemical compound C([C@H](NC(=O)[C@H](CCC(N)=O)N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 FTTHLXOMDMLKKW-FHWLQOOXSA-N 0.000 description 1
- XKPACHRGOWQHFH-IRIUXVKKSA-N Gln-Thr-Tyr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O XKPACHRGOWQHFH-IRIUXVKKSA-N 0.000 description 1
- RBSKVTZUFMIWFU-XEGUGMAKSA-N Gln-Trp-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](C)C(O)=O RBSKVTZUFMIWFU-XEGUGMAKSA-N 0.000 description 1
- WIMVKDYAKRAUCG-IHRRRGAJSA-N Gln-Tyr-Glu Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O WIMVKDYAKRAUCG-IHRRRGAJSA-N 0.000 description 1
- VDMABHYXBULDGN-LAEOZQHASA-N Gln-Val-Asp Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O VDMABHYXBULDGN-LAEOZQHASA-N 0.000 description 1
- BPDVTFBJZNBHEU-HGNGGELXSA-N Glu-Ala-His Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 BPDVTFBJZNBHEU-HGNGGELXSA-N 0.000 description 1
- NCWOMXABNYEPLY-NRPADANISA-N Glu-Ala-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O NCWOMXABNYEPLY-NRPADANISA-N 0.000 description 1
- CYHBMLHCQXXCCT-AVGNSLFASA-N Glu-Asp-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O CYHBMLHCQXXCCT-AVGNSLFASA-N 0.000 description 1
- GGJOGFJIPPGNRK-JSGCOSHPSA-N Glu-Gly-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)N)C(O)=O)=CNC2=C1 GGJOGFJIPPGNRK-JSGCOSHPSA-N 0.000 description 1
- QIQABBIDHGQXGA-ZPFDUUQYSA-N Glu-Ile-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O QIQABBIDHGQXGA-ZPFDUUQYSA-N 0.000 description 1
- HVYWQYLBVXMXSV-GUBZILKMSA-N Glu-Leu-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O HVYWQYLBVXMXSV-GUBZILKMSA-N 0.000 description 1
- GJBUAAAIZSRCDC-GVXVVHGQSA-N Glu-Leu-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O GJBUAAAIZSRCDC-GVXVVHGQSA-N 0.000 description 1
- OQXDUSZKISQQSS-GUBZILKMSA-N Glu-Lys-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O OQXDUSZKISQQSS-GUBZILKMSA-N 0.000 description 1
- SYAYROHMAIHWFB-KBIXCLLPSA-N Glu-Ser-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O SYAYROHMAIHWFB-KBIXCLLPSA-N 0.000 description 1
- HZISRJBYZAODRV-XQXXSGGOSA-N Glu-Thr-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O HZISRJBYZAODRV-XQXXSGGOSA-N 0.000 description 1
- RGJKYNUINKGPJN-RWRJDSDZSA-N Glu-Thr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(=O)O)N RGJKYNUINKGPJN-RWRJDSDZSA-N 0.000 description 1
- CQGBSALYGOXQPE-HTUGSXCWSA-N Glu-Thr-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O CQGBSALYGOXQPE-HTUGSXCWSA-N 0.000 description 1
- HGJREIGJLUQBTJ-SZMVWBNQSA-N Glu-Trp-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(O)=O HGJREIGJLUQBTJ-SZMVWBNQSA-N 0.000 description 1
- VXEFAWJTFAUDJK-AVGNSLFASA-N Glu-Tyr-Ser Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O VXEFAWJTFAUDJK-AVGNSLFASA-N 0.000 description 1
- PHONXOACARQMPM-BQBZGAKWSA-N Gly-Ala-Met Chemical compound [H]NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(O)=O PHONXOACARQMPM-BQBZGAKWSA-N 0.000 description 1
- DTPOVRRYXPJJAZ-FJXKBIBVSA-N Gly-Arg-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N DTPOVRRYXPJJAZ-FJXKBIBVSA-N 0.000 description 1
- WKJKBELXHCTHIJ-WPRPVWTQSA-N Gly-Arg-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N WKJKBELXHCTHIJ-WPRPVWTQSA-N 0.000 description 1
- GGEJHJIXRBTJPD-BYPYZUCNSA-N Gly-Asn-Gly Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O GGEJHJIXRBTJPD-BYPYZUCNSA-N 0.000 description 1
- XQHSBNVACKQWAV-WHFBIAKZSA-N Gly-Asp-Asn Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O XQHSBNVACKQWAV-WHFBIAKZSA-N 0.000 description 1
- QGZSAHIZRQHCEQ-QWRGUYRKSA-N Gly-Asp-Tyr Chemical compound NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 QGZSAHIZRQHCEQ-QWRGUYRKSA-N 0.000 description 1
- JLJLBWDKDRYOPA-RYUDHWBXSA-N Gly-Gln-Tyr Chemical compound NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 JLJLBWDKDRYOPA-RYUDHWBXSA-N 0.000 description 1
- CCQOOWAONKGYKQ-BYPYZUCNSA-N Gly-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)CN CCQOOWAONKGYKQ-BYPYZUCNSA-N 0.000 description 1
- KMSGYZQRXPUKGI-BYPYZUCNSA-N Gly-Gly-Asn Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC(N)=O KMSGYZQRXPUKGI-BYPYZUCNSA-N 0.000 description 1
- XPJBQTCXPJNIFE-ZETCQYMHSA-N Gly-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)CN XPJBQTCXPJNIFE-ZETCQYMHSA-N 0.000 description 1
- YWAQATDNEKZFFK-BYPYZUCNSA-N Gly-Gly-Ser Chemical compound NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O YWAQATDNEKZFFK-BYPYZUCNSA-N 0.000 description 1
- OLPPXYMMIARYAL-QMMMGPOBSA-N Gly-Gly-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)CNC(=O)CN OLPPXYMMIARYAL-QMMMGPOBSA-N 0.000 description 1
- HMHRTKOWRUPPNU-RCOVLWMOSA-N Gly-Ile-Gly Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O HMHRTKOWRUPPNU-RCOVLWMOSA-N 0.000 description 1
- UUYBFNKHOCJCHT-VHSXEESVSA-N Gly-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN UUYBFNKHOCJCHT-VHSXEESVSA-N 0.000 description 1
- MIIVFRCYJABHTQ-ONGXEEELSA-N Gly-Leu-Val Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O MIIVFRCYJABHTQ-ONGXEEELSA-N 0.000 description 1
- OQQKUTVULYLCDG-ONGXEEELSA-N Gly-Lys-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CN)C(O)=O OQQKUTVULYLCDG-ONGXEEELSA-N 0.000 description 1
- DHNXGWVNLFPOMQ-KBPBESRZSA-N Gly-Phe-His Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)CN DHNXGWVNLFPOMQ-KBPBESRZSA-N 0.000 description 1
- JYPCXBJRLBHWME-IUCAKERBSA-N Gly-Pro-Arg Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O JYPCXBJRLBHWME-IUCAKERBSA-N 0.000 description 1
- SSFWXSNOKDZNHY-QXEWZRGKSA-N Gly-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)CN SSFWXSNOKDZNHY-QXEWZRGKSA-N 0.000 description 1
- VNNRLUNBJSWZPF-ZKWXMUAHSA-N Gly-Ser-Ile Chemical compound [H]NCC(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VNNRLUNBJSWZPF-ZKWXMUAHSA-N 0.000 description 1
- ZKJZBRHRWKLVSJ-ZDLURKLDSA-N Gly-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)CN)O ZKJZBRHRWKLVSJ-ZDLURKLDSA-N 0.000 description 1
- RHRLHXQWHCNJKR-PMVVWTBXSA-N Gly-Thr-His Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 RHRLHXQWHCNJKR-PMVVWTBXSA-N 0.000 description 1
- WSWWTQYHFCBKBT-DVJZZOLTSA-N Gly-Thr-Trp Chemical compound C[C@@H](O)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O WSWWTQYHFCBKBT-DVJZZOLTSA-N 0.000 description 1
- ZNPRMNDAFQKATM-LKTVYLICSA-N His-Ala-Tyr Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZNPRMNDAFQKATM-LKTVYLICSA-N 0.000 description 1
- FIMNVXRZGUAGBI-AVGNSLFASA-N His-Glu-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O FIMNVXRZGUAGBI-AVGNSLFASA-N 0.000 description 1
- STWGDDDFLUFCCA-GVXVVHGQSA-N His-Glu-Val Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O STWGDDDFLUFCCA-GVXVVHGQSA-N 0.000 description 1
- FDQYIRHBVVUTJF-ZETCQYMHSA-N His-Gly-Gly Chemical compound [O-]C(=O)CNC(=O)CNC(=O)[C@@H]([NH3+])CC1=CN=CN1 FDQYIRHBVVUTJF-ZETCQYMHSA-N 0.000 description 1
- OZBDSFBWIDPVDA-BZSNNMDCSA-N His-His-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC3=CN=CN3)N OZBDSFBWIDPVDA-BZSNNMDCSA-N 0.000 description 1
- PGRPSOUCWRBWKZ-DLOVCJGASA-N His-Lys-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CN=CN1 PGRPSOUCWRBWKZ-DLOVCJGASA-N 0.000 description 1
- AYUOWUNWZGTNKB-ULQDDVLXSA-N His-Phe-Arg Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O AYUOWUNWZGTNKB-ULQDDVLXSA-N 0.000 description 1
- VXZZUXWAOMWWJH-QTKMDUPCSA-N His-Thr-Val Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O VXZZUXWAOMWWJH-QTKMDUPCSA-N 0.000 description 1
- MRVZCDSYLJXKKX-ACRUOGEOSA-N His-Tyr-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC3=CN=CN3)N MRVZCDSYLJXKKX-ACRUOGEOSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- JXUGDUWBMKIJDC-NAKRPEOUSA-N Ile-Ala-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O JXUGDUWBMKIJDC-NAKRPEOUSA-N 0.000 description 1
- NULSANWBUWLTKN-NAKRPEOUSA-N Ile-Arg-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(=O)O)N NULSANWBUWLTKN-NAKRPEOUSA-N 0.000 description 1
- YKRIXHPEIZUDDY-GMOBBJLQSA-N Ile-Asn-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YKRIXHPEIZUDDY-GMOBBJLQSA-N 0.000 description 1
- LJKDGRWXYUTRSH-YVNDNENWSA-N Ile-Gln-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N LJKDGRWXYUTRSH-YVNDNENWSA-N 0.000 description 1
- YBJWJQQBWRARLT-KBIXCLLPSA-N Ile-Gln-Ser Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O YBJWJQQBWRARLT-KBIXCLLPSA-N 0.000 description 1
- WZDCVAWMBUNDDY-KBIXCLLPSA-N Ile-Glu-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)O)N WZDCVAWMBUNDDY-KBIXCLLPSA-N 0.000 description 1
- KIMHKBDJQQYLHU-PEFMBERDSA-N Ile-Glu-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N KIMHKBDJQQYLHU-PEFMBERDSA-N 0.000 description 1
- NYEYYMLUABXDMC-NHCYSSNCSA-N Ile-Gly-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O)N NYEYYMLUABXDMC-NHCYSSNCSA-N 0.000 description 1
- WIZPFZKOFZXDQG-HTFCKZLJSA-N Ile-Ile-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O WIZPFZKOFZXDQG-HTFCKZLJSA-N 0.000 description 1
- HUORUFRRJHELPD-MNXVOIDGSA-N Ile-Leu-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N HUORUFRRJHELPD-MNXVOIDGSA-N 0.000 description 1
- UAELWXJFLZBKQS-WHOFXGATSA-N Ile-Phe-Gly Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(O)=O UAELWXJFLZBKQS-WHOFXGATSA-N 0.000 description 1
- XLXPYSDGMXTTNQ-UHFFFAOYSA-N Ile-Phe-Leu Natural products CCC(C)C(N)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=CC=C1 XLXPYSDGMXTTNQ-UHFFFAOYSA-N 0.000 description 1
- BATWGBRIZANGPN-ZPFDUUQYSA-N Ile-Pro-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)O)N BATWGBRIZANGPN-ZPFDUUQYSA-N 0.000 description 1
- FQYQMFCIJNWDQZ-CYDGBPFRSA-N Ile-Pro-Pro Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 FQYQMFCIJNWDQZ-CYDGBPFRSA-N 0.000 description 1
- XOZOSAUOGRPCES-STECZYCISA-N Ile-Pro-Tyr Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 XOZOSAUOGRPCES-STECZYCISA-N 0.000 description 1
- JZNVOBUNTWNZPW-GHCJXIJMSA-N Ile-Ser-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O)N JZNVOBUNTWNZPW-GHCJXIJMSA-N 0.000 description 1
- PELCGFMHLZXWBQ-BJDJZHNGSA-N Ile-Ser-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)N PELCGFMHLZXWBQ-BJDJZHNGSA-N 0.000 description 1
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 description 1
- HGCNKOLVKRAVHD-UHFFFAOYSA-N L-Met-L-Phe Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 HGCNKOLVKRAVHD-UHFFFAOYSA-N 0.000 description 1
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 1
- SITWEMZOJNKJCH-UHFFFAOYSA-N L-alanine-L-arginine Natural products CC(N)C(=O)NC(C(O)=O)CCCNC(N)=N SITWEMZOJNKJCH-UHFFFAOYSA-N 0.000 description 1
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 1
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 1
- KFKWRHQBZQICHA-STQMWFEESA-N L-leucyl-L-phenylalanine Natural products CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KFKWRHQBZQICHA-STQMWFEESA-N 0.000 description 1
- 101150048797 LIPH gene Proteins 0.000 description 1
- 108010029541 Laccase Proteins 0.000 description 1
- 241000880493 Leptailurus serval Species 0.000 description 1
- SUPVSFFZWVOEOI-CQDKDKBSSA-N Leu-Ala-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 SUPVSFFZWVOEOI-CQDKDKBSSA-N 0.000 description 1
- SUPVSFFZWVOEOI-UHFFFAOYSA-N Leu-Ala-Tyr Natural products CC(C)CC(N)C(=O)NC(C)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 SUPVSFFZWVOEOI-UHFFFAOYSA-N 0.000 description 1
- WUFYAPWIHCUMLL-CIUDSAMLSA-N Leu-Asn-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O WUFYAPWIHCUMLL-CIUDSAMLSA-N 0.000 description 1
- JKGHDYGZRDWHGA-SRVKXCTJSA-N Leu-Asn-Leu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O JKGHDYGZRDWHGA-SRVKXCTJSA-N 0.000 description 1
- FIJMQLGQLBLBOL-HJGDQZAQSA-N Leu-Asn-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FIJMQLGQLBLBOL-HJGDQZAQSA-N 0.000 description 1
- DLFAACQHIRSQGG-CIUDSAMLSA-N Leu-Asp-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O DLFAACQHIRSQGG-CIUDSAMLSA-N 0.000 description 1
- DLCOFDAHNMMQPP-SRVKXCTJSA-N Leu-Asp-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DLCOFDAHNMMQPP-SRVKXCTJSA-N 0.000 description 1
- MYGQXVYRZMKRDB-SRVKXCTJSA-N Leu-Asp-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN MYGQXVYRZMKRDB-SRVKXCTJSA-N 0.000 description 1
- FIYMBBHGYNQFOP-IUCAKERBSA-N Leu-Gly-Gln Chemical compound CC(C)C[C@@H](C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)O)N FIYMBBHGYNQFOP-IUCAKERBSA-N 0.000 description 1
- KXODZBLFVFSLAI-AVGNSLFASA-N Leu-His-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)CC1=CN=CN1 KXODZBLFVFSLAI-AVGNSLFASA-N 0.000 description 1
- XVZCXCTYGHPNEM-UHFFFAOYSA-N Leu-Leu-Pro Natural products CC(C)CC(N)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(O)=O XVZCXCTYGHPNEM-UHFFFAOYSA-N 0.000 description 1
- RXGLHDWAZQECBI-SRVKXCTJSA-N Leu-Leu-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O RXGLHDWAZQECBI-SRVKXCTJSA-N 0.000 description 1
- MUCIDQMDOYQYBR-IHRRRGAJSA-N Leu-Pro-His Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N MUCIDQMDOYQYBR-IHRRRGAJSA-N 0.000 description 1
- XXXXOVFBXRERQL-ULQDDVLXSA-N Leu-Pro-Phe Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 XXXXOVFBXRERQL-ULQDDVLXSA-N 0.000 description 1
- IRMLZWSRWSGTOP-CIUDSAMLSA-N Leu-Ser-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O IRMLZWSRWSGTOP-CIUDSAMLSA-N 0.000 description 1
- KZZCOWMDDXDKSS-CIUDSAMLSA-N Leu-Ser-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O KZZCOWMDDXDKSS-CIUDSAMLSA-N 0.000 description 1
- GZRABTMNWJXFMH-UVOCVTCTSA-N Leu-Thr-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GZRABTMNWJXFMH-UVOCVTCTSA-N 0.000 description 1
- CGHXMODRYJISSK-NHCYSSNCSA-N Leu-Val-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC(O)=O CGHXMODRYJISSK-NHCYSSNCSA-N 0.000 description 1
- VKVDRTGWLVZJOM-DCAQKATOSA-N Leu-Val-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O VKVDRTGWLVZJOM-DCAQKATOSA-N 0.000 description 1
- KCXUCYYZNZFGLL-SRVKXCTJSA-N Lys-Ala-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O KCXUCYYZNZFGLL-SRVKXCTJSA-N 0.000 description 1
- WXJKFRMKJORORD-DCAQKATOSA-N Lys-Arg-Ala Chemical compound NC(=N)NCCC[C@@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@@H](N)CCCCN WXJKFRMKJORORD-DCAQKATOSA-N 0.000 description 1
- RZHLIPMZXOEJTL-AVGNSLFASA-N Lys-Gln-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCCN)N RZHLIPMZXOEJTL-AVGNSLFASA-N 0.000 description 1
- VQXAVLQBQJMENB-SRVKXCTJSA-N Lys-Glu-Met Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(O)=O VQXAVLQBQJMENB-SRVKXCTJSA-N 0.000 description 1
- QZONCCHVHCOBSK-YUMQZZPRSA-N Lys-Gly-Asn Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O QZONCCHVHCOBSK-YUMQZZPRSA-N 0.000 description 1
- SKRGVGLIRUGANF-AVGNSLFASA-N Lys-Leu-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SKRGVGLIRUGANF-AVGNSLFASA-N 0.000 description 1
- QBHGXFQJFPWJIH-XUXIUFHCSA-N Lys-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN QBHGXFQJFPWJIH-XUXIUFHCSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- QEVRUYFHWJJUHZ-DCAQKATOSA-N Met-Ala-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(C)C QEVRUYFHWJJUHZ-DCAQKATOSA-N 0.000 description 1
- WYEXWKAWMNJKPN-UBHSHLNASA-N Met-Ala-Phe Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCSC)N WYEXWKAWMNJKPN-UBHSHLNASA-N 0.000 description 1
- UAPZLLPGGOOCRO-IHRRRGAJSA-N Met-Asn-Phe Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N UAPZLLPGGOOCRO-IHRRRGAJSA-N 0.000 description 1
- HHCOOFPGNXKFGR-HJGDQZAQSA-N Met-Gln-Thr Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O HHCOOFPGNXKFGR-HJGDQZAQSA-N 0.000 description 1
- UYAKZHGIPRCGPF-CIUDSAMLSA-N Met-Glu-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)N UYAKZHGIPRCGPF-CIUDSAMLSA-N 0.000 description 1
- ORRNBLTZBBESPN-HJWJTTGWSA-N Met-Ile-Phe Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 ORRNBLTZBBESPN-HJWJTTGWSA-N 0.000 description 1
- CGUYGMFQZCYJSG-DCAQKATOSA-N Met-Lys-Ser Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O CGUYGMFQZCYJSG-DCAQKATOSA-N 0.000 description 1
- OBPCXINRFKHSRY-SDDRHHMPSA-N Met-Met-Pro Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@@H]1C(=O)O)N OBPCXINRFKHSRY-SDDRHHMPSA-N 0.000 description 1
- CIDICGYKRUTYLE-FXQIFTODSA-N Met-Ser-Ala Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O CIDICGYKRUTYLE-FXQIFTODSA-N 0.000 description 1
- ZBLSZPYQQRIHQU-RCWTZXSCSA-N Met-Thr-Val Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O ZBLSZPYQQRIHQU-RCWTZXSCSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 1
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 1
- 108010079364 N-glycylalanine Proteins 0.000 description 1
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 1
- 101100342977 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) leu-1 gene Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108700020962 Peroxidase Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- BJEYSVHMGIJORT-NHCYSSNCSA-N Phe-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 BJEYSVHMGIJORT-NHCYSSNCSA-N 0.000 description 1
- FPTXMUIBLMGTQH-ONGXEEELSA-N Phe-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 FPTXMUIBLMGTQH-ONGXEEELSA-N 0.000 description 1
- FRPVPGRXUKFEQE-YDHLFZDLSA-N Phe-Asp-Val Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O FRPVPGRXUKFEQE-YDHLFZDLSA-N 0.000 description 1
- WPTYDQPGBMDUBI-QWRGUYRKSA-N Phe-Gly-Asn Chemical compound N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O WPTYDQPGBMDUBI-QWRGUYRKSA-N 0.000 description 1
- NAXPHWZXEXNDIW-JTQLQIEISA-N Phe-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 NAXPHWZXEXNDIW-JTQLQIEISA-N 0.000 description 1
- BEEVXUYVEHXWRQ-YESZJQIVSA-N Phe-His-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC3=CC=CC=C3)N)C(=O)O BEEVXUYVEHXWRQ-YESZJQIVSA-N 0.000 description 1
- BWTKUQPNOMMKMA-FIRPJDEBSA-N Phe-Ile-Phe Chemical compound C([C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 BWTKUQPNOMMKMA-FIRPJDEBSA-N 0.000 description 1
- KBVJZCVLQWCJQN-KKUMJFAQSA-N Phe-Leu-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O KBVJZCVLQWCJQN-KKUMJFAQSA-N 0.000 description 1
- YKUGPVXSDOOANW-KKUMJFAQSA-N Phe-Leu-Asp Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O YKUGPVXSDOOANW-KKUMJFAQSA-N 0.000 description 1
- RVEVENLSADZUMS-IHRRRGAJSA-N Phe-Pro-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O RVEVENLSADZUMS-IHRRRGAJSA-N 0.000 description 1
- BSKMOCNNLNDIMU-CDMKHQONSA-N Phe-Thr-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O BSKMOCNNLNDIMU-CDMKHQONSA-N 0.000 description 1
- QTDBZORPVYTRJU-KKXDTOCCSA-N Phe-Tyr-Ala Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O QTDBZORPVYTRJU-KKXDTOCCSA-N 0.000 description 1
- GOUWCZRDTWTODO-YDHLFZDLSA-N Phe-Val-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O GOUWCZRDTWTODO-YDHLFZDLSA-N 0.000 description 1
- KUSYCSMTTHSZOA-DZKIICNBSA-N Phe-Val-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N KUSYCSMTTHSZOA-DZKIICNBSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- KIZQGKLMXKGDIV-BQBZGAKWSA-N Pro-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 KIZQGKLMXKGDIV-BQBZGAKWSA-N 0.000 description 1
- KTFZQPLSPLWLKN-KKUMJFAQSA-N Pro-Gln-Tyr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O KTFZQPLSPLWLKN-KKUMJFAQSA-N 0.000 description 1
- LGSANCBHSMDFDY-GARJFASQSA-N Pro-Glu-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCC[C@@H]2C(=O)O LGSANCBHSMDFDY-GARJFASQSA-N 0.000 description 1
- UEHYFUCOGHWASA-HJGDQZAQSA-N Pro-Glu-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1 UEHYFUCOGHWASA-HJGDQZAQSA-N 0.000 description 1
- UUHXBJHVTVGSKM-BQBZGAKWSA-N Pro-Gly-Asn Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O UUHXBJHVTVGSKM-BQBZGAKWSA-N 0.000 description 1
- FEPSEIDIPBMIOS-QXEWZRGKSA-N Pro-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 FEPSEIDIPBMIOS-QXEWZRGKSA-N 0.000 description 1
- DXTOOBDIIAJZBJ-BQBZGAKWSA-N Pro-Gly-Ser Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CO)C(O)=O DXTOOBDIIAJZBJ-BQBZGAKWSA-N 0.000 description 1
- VWXGFAIZUQBBBG-UWVGGRQHSA-N Pro-His-Gly Chemical compound C([C@@H](C(=O)NCC(=O)[O-])NC(=O)[C@H]1[NH2+]CCC1)C1=CN=CN1 VWXGFAIZUQBBBG-UWVGGRQHSA-N 0.000 description 1
- FXGIMYRVJJEIIM-UWVGGRQHSA-N Pro-Leu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1 FXGIMYRVJJEIIM-UWVGGRQHSA-N 0.000 description 1
- ZVEQWRWMRFIVSD-HRCADAONSA-N Pro-Phe-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N3CCC[C@@H]3C(=O)O ZVEQWRWMRFIVSD-HRCADAONSA-N 0.000 description 1
- SPLBRAKYXGOFSO-UNQGMJICSA-N Pro-Phe-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H]2CCCN2)O SPLBRAKYXGOFSO-UNQGMJICSA-N 0.000 description 1
- LEIKGVHQTKHOLM-IUCAKERBSA-N Pro-Pro-Gly Chemical compound OC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 LEIKGVHQTKHOLM-IUCAKERBSA-N 0.000 description 1
- AJJDPGVVNPUZCR-RHYQMDGZSA-N Pro-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@@H]1CCCN1)O AJJDPGVVNPUZCR-RHYQMDGZSA-N 0.000 description 1
- YHUBAXGAAYULJY-ULQDDVLXSA-N Pro-Tyr-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O YHUBAXGAAYULJY-ULQDDVLXSA-N 0.000 description 1
- FUOGXAQMNJMBFG-WPRPVWTQSA-N Pro-Val-Gly Chemical compound OC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 FUOGXAQMNJMBFG-WPRPVWTQSA-N 0.000 description 1
- ZUGXSSFMTXKHJS-ZLUOBGJFSA-N Ser-Ala-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O ZUGXSSFMTXKHJS-ZLUOBGJFSA-N 0.000 description 1
- BTKUIVBNGBFTTP-WHFBIAKZSA-N Ser-Ala-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(O)=O BTKUIVBNGBFTTP-WHFBIAKZSA-N 0.000 description 1
- DWUIECHTAMYEFL-XVYDVKMFSA-N Ser-Ala-His Chemical compound OC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 DWUIECHTAMYEFL-XVYDVKMFSA-N 0.000 description 1
- HBZBPFLJNDXRAY-FXQIFTODSA-N Ser-Ala-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O HBZBPFLJNDXRAY-FXQIFTODSA-N 0.000 description 1
- OYEDZGNMSBZCIM-XGEHTFHBSA-N Ser-Arg-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OYEDZGNMSBZCIM-XGEHTFHBSA-N 0.000 description 1
- VAUMZJHYZQXZBQ-WHFBIAKZSA-N Ser-Asn-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O VAUMZJHYZQXZBQ-WHFBIAKZSA-N 0.000 description 1
- RDFQNDHEHVSONI-ZLUOBGJFSA-N Ser-Asn-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O RDFQNDHEHVSONI-ZLUOBGJFSA-N 0.000 description 1
- SWSRFJZZMNLMLY-ZKWXMUAHSA-N Ser-Asp-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O SWSRFJZZMNLMLY-ZKWXMUAHSA-N 0.000 description 1
- LALNXSXEYFUUDD-GUBZILKMSA-N Ser-Glu-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O LALNXSXEYFUUDD-GUBZILKMSA-N 0.000 description 1
- UIGMAMGZOJVTDN-WHFBIAKZSA-N Ser-Gly-Ser Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O UIGMAMGZOJVTDN-WHFBIAKZSA-N 0.000 description 1
- ZUDXUJSYCCNZQJ-DCAQKATOSA-N Ser-His-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CO)N ZUDXUJSYCCNZQJ-DCAQKATOSA-N 0.000 description 1
- VMLONWHIORGALA-SRVKXCTJSA-N Ser-Leu-Leu Chemical compound CC(C)C[C@@H](C([O-])=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CO VMLONWHIORGALA-SRVKXCTJSA-N 0.000 description 1
- IXZHZUGGKLRHJD-DCAQKATOSA-N Ser-Leu-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O IXZHZUGGKLRHJD-DCAQKATOSA-N 0.000 description 1
- RRVFEDGUXSYWOW-BZSNNMDCSA-N Ser-Phe-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O RRVFEDGUXSYWOW-BZSNNMDCSA-N 0.000 description 1
- ADJDNJCSPNFFPI-FXQIFTODSA-N Ser-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO ADJDNJCSPNFFPI-FXQIFTODSA-N 0.000 description 1
- GZGFSPWOMUKKCV-NAKRPEOUSA-N Ser-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO GZGFSPWOMUKKCV-NAKRPEOUSA-N 0.000 description 1
- FLONGDPORFIVQW-XGEHTFHBSA-N Ser-Pro-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO FLONGDPORFIVQW-XGEHTFHBSA-N 0.000 description 1
- PMTWIUBUQRGCSB-FXQIFTODSA-N Ser-Val-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O PMTWIUBUQRGCSB-FXQIFTODSA-N 0.000 description 1
- UKKROEYWYIHWBD-ZKWXMUAHSA-N Ser-Val-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O UKKROEYWYIHWBD-ZKWXMUAHSA-N 0.000 description 1
- LLSLRQOEAFCZLW-NRPADANISA-N Ser-Val-Gln Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O LLSLRQOEAFCZLW-NRPADANISA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 108700005078 Synthetic Genes Proteins 0.000 description 1
- TYVAWPFQYFPSBR-BFHQHQDPSA-N Thr-Ala-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(O)=O TYVAWPFQYFPSBR-BFHQHQDPSA-N 0.000 description 1
- BSNZTJXVDOINSR-JXUBOQSCSA-N Thr-Ala-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O BSNZTJXVDOINSR-JXUBOQSCSA-N 0.000 description 1
- KEGBFULVYKYJRD-LFSVMHDDSA-N Thr-Ala-Phe Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KEGBFULVYKYJRD-LFSVMHDDSA-N 0.000 description 1
- CAJFZCICSVBOJK-SHGPDSBTSA-N Thr-Ala-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CAJFZCICSVBOJK-SHGPDSBTSA-N 0.000 description 1
- GZYNMZQXFRWDFH-YTWAJWBKSA-N Thr-Arg-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)O)N)O GZYNMZQXFRWDFH-YTWAJWBKSA-N 0.000 description 1
- VIBXMCZWVUOZLA-OLHMAJIHSA-N Thr-Asn-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O VIBXMCZWVUOZLA-OLHMAJIHSA-N 0.000 description 1
- NLJKZUGAIIRWJN-LKXGYXEUSA-N Thr-Asp-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)O)N)O NLJKZUGAIIRWJN-LKXGYXEUSA-N 0.000 description 1
- MMTOHPRBJKEZHT-BWBBJGPYSA-N Thr-Cys-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O MMTOHPRBJKEZHT-BWBBJGPYSA-N 0.000 description 1
- DIPIPFHFLPTCLK-LOKLDPHHSA-N Thr-Gln-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N)O DIPIPFHFLPTCLK-LOKLDPHHSA-N 0.000 description 1
- CQNFRKAKGDSJFR-NUMRIWBASA-N Thr-Glu-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O CQNFRKAKGDSJFR-NUMRIWBASA-N 0.000 description 1
- QQWNRERCGGZOKG-WEDXCCLWSA-N Thr-Gly-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O QQWNRERCGGZOKG-WEDXCCLWSA-N 0.000 description 1
- VUSAEKOXGNEYNE-PBCZWWQYSA-N Thr-His-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O VUSAEKOXGNEYNE-PBCZWWQYSA-N 0.000 description 1
- AHOLTQCAVBSUDP-PPCPHDFISA-N Thr-Ile-Lys Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O AHOLTQCAVBSUDP-PPCPHDFISA-N 0.000 description 1
- KZSYAEWQMJEGRZ-RHYQMDGZSA-N Thr-Leu-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O KZSYAEWQMJEGRZ-RHYQMDGZSA-N 0.000 description 1
- KZURUCDWKDEAFZ-XVSYOHENSA-N Thr-Phe-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O KZURUCDWKDEAFZ-XVSYOHENSA-N 0.000 description 1
- MXDOAJQRJBMGMO-FJXKBIBVSA-N Thr-Pro-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O MXDOAJQRJBMGMO-FJXKBIBVSA-N 0.000 description 1
- NDZYTIMDOZMECO-SHGPDSBTSA-N Thr-Thr-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O NDZYTIMDOZMECO-SHGPDSBTSA-N 0.000 description 1
- ZESGVALRVJIVLZ-VFCFLDTKSA-N Thr-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@@H]1C(=O)O)N)O ZESGVALRVJIVLZ-VFCFLDTKSA-N 0.000 description 1
- QGVBFDIREUUSHX-IFFSRLJSSA-N Thr-Val-Gln Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O QGVBFDIREUUSHX-IFFSRLJSSA-N 0.000 description 1
- AKHDFZHUPGVFEJ-YEPSODPASA-N Thr-Val-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O AKHDFZHUPGVFEJ-YEPSODPASA-N 0.000 description 1
- AWYXDHQQFPZJNE-QEJZJMRPSA-N Trp-Gln-Ser Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N AWYXDHQQFPZJNE-QEJZJMRPSA-N 0.000 description 1
- RQLNEFOBQAVGSY-WDSOQIARSA-N Trp-Met-Leu Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O RQLNEFOBQAVGSY-WDSOQIARSA-N 0.000 description 1
- BGWSLEYVITZIQP-DCPHZVHLSA-N Trp-Phe-Ala Chemical compound C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(O)=O BGWSLEYVITZIQP-DCPHZVHLSA-N 0.000 description 1
- GQEXFCQNAJHJTI-IHPCNDPISA-N Trp-Phe-Asp Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N GQEXFCQNAJHJTI-IHPCNDPISA-N 0.000 description 1
- DTPWXZXGFAHEKL-NWLDYVSISA-N Trp-Thr-Glu Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O DTPWXZXGFAHEKL-NWLDYVSISA-N 0.000 description 1
- ZRPLVTZTKPPSBT-AVGNSLFASA-N Tyr-Glu-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O ZRPLVTZTKPPSBT-AVGNSLFASA-N 0.000 description 1
- AKLNEFNQWLHIGY-QWRGUYRKSA-N Tyr-Gly-Asp Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)N)O AKLNEFNQWLHIGY-QWRGUYRKSA-N 0.000 description 1
- CTDPLKMBVALCGN-JSGCOSHPSA-N Tyr-Gly-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O CTDPLKMBVALCGN-JSGCOSHPSA-N 0.000 description 1
- PJWCWGXAVIVXQC-STECZYCISA-N Tyr-Ile-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 PJWCWGXAVIVXQC-STECZYCISA-N 0.000 description 1
- MQGGXGKQSVEQHR-KKUMJFAQSA-N Tyr-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 MQGGXGKQSVEQHR-KKUMJFAQSA-N 0.000 description 1
- 101710147108 Tyrosinase inhibitor Proteins 0.000 description 1
- AZSHAZJLOZQYAY-FXQIFTODSA-N Val-Ala-Ser Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O AZSHAZJLOZQYAY-FXQIFTODSA-N 0.000 description 1
- VMRFIKXKOFNMHW-GUBZILKMSA-N Val-Arg-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(=O)O)N VMRFIKXKOFNMHW-GUBZILKMSA-N 0.000 description 1
- UDNYEPLJTRDMEJ-RCOVLWMOSA-N Val-Asn-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)O)N UDNYEPLJTRDMEJ-RCOVLWMOSA-N 0.000 description 1
- GNWUWQAVVJQREM-NHCYSSNCSA-N Val-Asn-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N GNWUWQAVVJQREM-NHCYSSNCSA-N 0.000 description 1
- CGGVNFJRZJUVAE-BYULHYEWSA-N Val-Asp-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N CGGVNFJRZJUVAE-BYULHYEWSA-N 0.000 description 1
- TZVUSFMQWPWHON-NHCYSSNCSA-N Val-Asp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)N TZVUSFMQWPWHON-NHCYSSNCSA-N 0.000 description 1
- DDNIHOWRDOXXPF-NGZCFLSTSA-N Val-Asp-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N DDNIHOWRDOXXPF-NGZCFLSTSA-N 0.000 description 1
- COSLEEOIYRPTHD-YDHLFZDLSA-N Val-Asp-Tyr Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 COSLEEOIYRPTHD-YDHLFZDLSA-N 0.000 description 1
- GBESYURLQOYWLU-LAEOZQHASA-N Val-Glu-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N GBESYURLQOYWLU-LAEOZQHASA-N 0.000 description 1
- FOADDSDHGRFUOC-DZKIICNBSA-N Val-Glu-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N FOADDSDHGRFUOC-DZKIICNBSA-N 0.000 description 1
- OQWNEUXPKHIEJO-NRPADANISA-N Val-Glu-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)N OQWNEUXPKHIEJO-NRPADANISA-N 0.000 description 1
- XWYUBUYQMOUFRQ-IFFSRLJSSA-N Val-Glu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)N)O XWYUBUYQMOUFRQ-IFFSRLJSSA-N 0.000 description 1
- FEFZWCSXEMVSPO-LSJOCFKGSA-N Val-His-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](C)C(O)=O FEFZWCSXEMVSPO-LSJOCFKGSA-N 0.000 description 1
- DLMNFMXSNGTSNJ-PYJNHQTQSA-N Val-His-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](C(C)C)N DLMNFMXSNGTSNJ-PYJNHQTQSA-N 0.000 description 1
- SYSWVVCYSXBVJG-RHYQMDGZSA-N Val-Leu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)N)O SYSWVVCYSXBVJG-RHYQMDGZSA-N 0.000 description 1
- ZRSZTKTVPNSUNA-IHRRRGAJSA-N Val-Lys-Leu Chemical compound CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(O)=O ZRSZTKTVPNSUNA-IHRRRGAJSA-N 0.000 description 1
- UXODSMTVPWXHBT-ULQDDVLXSA-N Val-Phe-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N UXODSMTVPWXHBT-ULQDDVLXSA-N 0.000 description 1
- VHIZXDZMTDVFGX-DCAQKATOSA-N Val-Ser-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N VHIZXDZMTDVFGX-DCAQKATOSA-N 0.000 description 1
- DLLRRUDLMSJTMB-GUBZILKMSA-N Val-Ser-Met Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)O)N DLLRRUDLMSJTMB-GUBZILKMSA-N 0.000 description 1
- GBIUHAYJGWVNLN-UHFFFAOYSA-N Val-Ser-Pro Natural products CC(C)C(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O GBIUHAYJGWVNLN-UHFFFAOYSA-N 0.000 description 1
- QPJSIBAOZBVELU-BPNCWPANSA-N Val-Tyr-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C(C)C)N QPJSIBAOZBVELU-BPNCWPANSA-N 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 108010024078 alanyl-glycyl-serine Proteins 0.000 description 1
- 108010005233 alanylglutamic acid Proteins 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- 108010070944 alanylhistidine Proteins 0.000 description 1
- 108010050025 alpha-glutamyltryptophan Proteins 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 108010013835 arginine glutamate Proteins 0.000 description 1
- 108010060035 arginylproline Proteins 0.000 description 1
- 108010036533 arginylvaline Proteins 0.000 description 1
- 108010077245 asparaginyl-proline Proteins 0.000 description 1
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 239000013000 chemical inhibitor Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 108010046301 glucose peroxidase Proteins 0.000 description 1
- 108010057083 glutamyl-aspartyl-leucine Proteins 0.000 description 1
- JYPCXBJRLBHWME-UHFFFAOYSA-N glycyl-L-prolyl-L-arginine Natural products NCC(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C(O)=O JYPCXBJRLBHWME-UHFFFAOYSA-N 0.000 description 1
- 108010019832 glycyl-asparaginyl-glycine Proteins 0.000 description 1
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Natural products NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 1
- 108010026364 glycyl-glycyl-leucine Proteins 0.000 description 1
- 108010025801 glycyl-prolyl-arginine Proteins 0.000 description 1
- 108010079413 glycyl-prolyl-glutamic acid Proteins 0.000 description 1
- 108010010147 glycylglutamine Proteins 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 108010092114 histidylphenylalanine Proteins 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 108010044311 leucyl-glycyl-glycine Proteins 0.000 description 1
- 108010034529 leucyl-lysine Proteins 0.000 description 1
- 108010057821 leucylproline Proteins 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 108010054155 lysyllysine Proteins 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 230000008101 melanin synthesis pathway Effects 0.000 description 1
- 108010005942 methionylglycine Proteins 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 108010070409 phenylalanyl-glycyl-glycine Proteins 0.000 description 1
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 1
- 108010051242 phenylalanylserine Proteins 0.000 description 1
- 108010025488 pinealon Proteins 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 239000012165 plant wax Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 108700042769 prolyl-leucyl-glycine Proteins 0.000 description 1
- 108010087846 prolyl-prolyl-glycine Proteins 0.000 description 1
- 108010004914 prolylarginine Proteins 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 108010026333 seryl-proline Proteins 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 108010061238 threonyl-glycine Proteins 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/22—Peroxides; Oxygen; Ozone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
리그닌 과산화효소(Lignin Peroxidase)를 포함하는 피부 미백용 화장료 조성물은 피부 부작용이 매우 적으며, 멜라닌을 선택적으로 탈색할 뿐만 아니라 멜라닌 탈색 효율이 매우 뛰어나다. 나아가, 포도당 산화효소를 포함하는 조성물의 경우, 저농도의 과산화수소의 연속적인 공급을 통해 멜라닌의 탈색 효율이 더욱 증진되므로, 상기 조성물을 피부 미백용도로 이용할 수 있다.
또한, 상기 조성물을 이용한 피부 내 멜라닌의 탈색 방법 또한, 멜라닌을 선택적으로 탈색시키며, 그 효율이 우수하여 적용된 개체의 피부 미백 효과를 달성할 수 있다.A cosmetic composition for skin whitening containing lignin peroxidase has very few skin side effects, selectively bleaching melanin, and excellent melanin bleaching efficiency. Further, in the case of a composition containing glucose oxidase, since the decolorization efficiency of melanin is further enhanced through continuous supply of low concentration hydrogen peroxide, the composition can be used for skin whitening.
In addition, the method of decolorizing melanin in the skin using the composition also selectively decolorizes melanin, and its efficiency is excellent, so that the skin whitening effect of the applied individual can be achieved.
Description
리그닌 과산화효소를 포함하는 피부 미백용 화장료 조성물 및 이를 이용한 피부 내 멜라닌의 탈색 방법에 관한 것이다.It relates to a cosmetic composition for skin whitening comprising lignin peroxidase and a method for bleaching melanin in the skin using the same.
멜라닌은 자외선으로부터 피부를 보호하는 데 중요한 역할을 하는데, 이는 멜라닌이 자외선을 포함한 대부분의 파장의 빛을 여과하는 것이다. 이러한 이유로, 멜라닌의 대부분은 표피에 위치하고 피부의 색을 결정한다. 멜라닌에는 유멜라닌과 페오멜라닌 두 종류가 있으며, 유멜라닌은 검은색 또는 갈색을 나타내며, 페오멜라닌은 빨간색 또는 노란색을 나타낸다. Melanin plays an important role in protecting the skin from UV rays, which is by filtering out most wavelengths of light, including UV rays. For this reason, most of the melanin is located in the epidermis and determines the color of the skin. There are two types of melanin, eumelanin and pheomelanin, eumelanin represents black or brown, and pheomelanin represents red or yellow.
한편, 피부에 존재하는 멜라닌은 멜라닌 합성 경로에서 L-DOPA (L-3,4-dihydroxyphenylalanine)는 도파 퀴논으로 전환되고, 티로시나아제에 의해 생성된다. 이에 따라, 현재까지 미백화장품에 다양한 종류의 티로시나아제 억제제가 세포에서 멜라닌 생성을 줄이기 위해 가장 활발히 연구되고 있다. 그러나 이러한 타이로시나제의 화학적 저해제는 백반증과 같은 많은 잠재적 부작용을 나타냈으며, 대표적으로 많은 사람들이 강력한 티로시나아제 억제제인 rhododenol로 인해 고통 받고 있다.On the other hand, melanin present in the skin is converted to dopaquinone in the melanin synthesis pathway, L-DOPA (L-3,4-dihydroxyphenylalanine), and is produced by tyrosinase. Accordingly, to date, various types of tyrosinase inhibitors in whitening cosmetics have been most actively studied to reduce melanin production in cells. However, these chemical inhibitors of tyrosinase have many potential side effects, such as vitiligo, and many people suffer from rhododenol, a powerful tyrosinase inhibitor.
이러한 이유로, 효소가 피부 표면에 존재하는 멜라닌을 선택적으로 탈색시키기 위해 화학 물질 대신 효소를 사용하여 멜라닌을 탈색시키는 연구가 진행되고 있다. 라카아제(laccase), dye-decolorizing peroxidase, 망간 과산화효소(manganese peroxidase) 및 리그닌 과산화효소(lignin peroxidase)와 같은 다른 과산화효소들은 이미 테스트를 거쳤으나, 망간 과산화효소는 효율적인 멜라닌 탈색을 위해 망간 중금속 이온 또는 합성 매개체를 필요로 하며, 이들은 인간의 피부에 독성을 나타낼 수 있다. 리그닌 과산화효소는 이러한 물질을 필요로 하지 않으며, 심지어 베라틸 알콜을 산화시킬 수 있는 높은 산화 환원 전위를 나타내기 때문에 다른 효소보다 훨씬 효과적으로 멜라닌을 탈색시키는 유망한 촉매제이다. 그에 비하여 다른 효소는 멜라닌을 산화시키기에 덜 효과적인 산화 환원 전위를 나타낸다. 그러나 멜라닌 탈색 효소로서 높은 잠재력을 지니고 있음에도 불구하고, 리그닌 과산화효소는 백색 부후균류(Phanerocaete chrysosporium)로부터 최대 17개의 다른 동종 효소를 생합성되기 때문에 발현 및 정제의 어려움으로 인해 정제되지 않은 미정제 효소로만 연구되고 사용되어 왔다. 또한, 리그닌 과산화효소는 과도한 양의 과산화수소(H2O2)에 의해 쉽게 불활성화 될 수 있는데, 이는 효소를 비활성화시켜 멜라닌 탈색 효율을 증가시키는 것을 억제하는 주요 장애물이었다.For this reason, studies in which enzymes use enzymes instead of chemicals to decolor melanin present on the skin surface are being conducted in order to selectively decolorize melanin present on the skin surface. Other peroxidases such as laccase, dye-decolorizing peroxidase, manganese peroxidase and lignin peroxidase have already been tested, but manganese peroxidase is a manganese heavy metal ion for efficient melanin decolorization. Or require synthetic mediators, which can be toxic to human skin. Lignin peroxidase is a promising catalyst that decolorizes melanin much more effectively than other enzymes because it does not require these substances and even exhibits a high redox potential capable of oxidizing verayl alcohol. In contrast, other enzymes exhibit a less effective redox potential to oxidize melanin. However, despite its high potential as a melanin decolorizing enzyme, lignin peroxidase is only studied as an unpurified enzyme due to difficulty in expression and purification because it biosynthesizes up to 17 other homologous enzymes from Phanerocaete chrysosporium. And have been used. In addition, lignin peroxidase can be easily inactivated by an excessive amount of hydrogen peroxide (H 2 O 2 ), which was a major obstacle to inhibiting the increase in melanin bleaching efficiency by inactivating the enzyme.
이에 따라, 정제된 리그닌 과산화효소를 이용하여 단시간 내에 선택적으로 피부 내 멜라닌을 탈색할 뿐만 아니라 멜라닌 탈색 효율을 증진시켜 미백화장품의 주요 소재 및 기술로 적용하고자 한다.Accordingly, the purified lignin peroxidase is used to selectively decolorize melanin in the skin within a short time, as well as improve melanin decolorization efficiency to be applied as a major material and technology for whitening cosmetics.
일 양상은 리그닌 과산화효소(Lignin Peroxidase)를 포함하는 피부 미백용 화장료 조성물을 제공하는 것이다.One aspect is to provide a cosmetic composition for skin whitening comprising lignin peroxidase.
다른 양상은 개체의 피부에 상기 조성물을 적용하는 단계를 포함하는 피부 내 멜라닌의 탈색 방법을 제공하는 것이다.Another aspect is to provide a method for depigmenting melanin in the skin comprising applying the composition to the skin of a subject.
또 다른 양상은 개체의 피부에 리그닌 과산화효소, 베라트릴 알코올 및 과산화수소를 적용하는 단계를 포함하는 피부 내 멜라닌의 탈색 방법을 제공하는 것이다.Another aspect is to provide a method for depigmenting melanin in skin comprising applying lignin peroxidase, veratrile alcohol, and hydrogen peroxide to the skin of an individual.
일 양상은 리그닌 과산화효소(Lignin Peroxidase)를 포함하는 피부 미백용 화장료 조성물을 제공한다.One aspect provides a cosmetic composition for skin whitening comprising lignin peroxidase.
상기 리그닌 과산화효소는 베라트릴 알코올과 과산화수소(H2O2)가 반응하여 물(H2O)과 베라트릴 알코올 양이온 라디칼을 생성하는 반응을 촉매한다.The lignin peroxidase catalyzes a reaction in which veratryl alcohol and hydrogen peroxide (H 2 O 2 ) react to generate water (H 2 O) and veratryl alcohol cation radicals.
상기 생성된 베라트릴 알코올 양이온은 멜라닌과 반응하여 베라트릴 알코올 형성과 동시에 멜라닌을 탈색시켜, 피부 미백 효과를 달성할 수 있다.The generated veratryl alcohol cation reacts with melanin to form veratryl alcohol and decolorizes melanin at the same time, thereby achieving a skin whitening effect.
상기 조성물은 멜라닌을 선택적으로 탈색할 뿐만 아니라 멜라닌 탈색 효율이 매우 우수하여 피부 미백 효과가 우수하며, 피부 부작용이 매우 적다.The composition not only selectively decolorizes melanin, but also has very excellent melanin decolorization efficiency, has excellent skin whitening effect, and has very few skin side effects.
상기 리그닌 과산화효소는 천연으로부터 유래될 수도 있고, 당해 분야에서 널리 공지된 다양한 단백질 합성 방법으로 획득할 수 있다. 일례로서, 폴리뉴클레오티드 재조합과 단백질 발현 시스템을 이용하여 제조하거나 단백질 합성과 같은 화학적 합성을 통하여 시험관 내에서 합성하는 방법 및 무세포 단백질 합성법 등으로 제조될 수 있다. 또한, 일례로서, 상기 리그닌 과산화효소는 펩티드, 식물 유래 조직이나 세포의 추출물, 미생물(예를 들어 세균류 또는 진균류, 그리고 특히 효모)의 배양으로 얻어진 생산물일 수 있다.The lignin peroxidase may be derived from nature or may be obtained by various protein synthesis methods well known in the art. As an example, it may be prepared by using a polynucleotide recombination and protein expression system, or by a method of in vitro synthesis through chemical synthesis such as protein synthesis, a cell-free protein synthesis method, and the like. In addition, as an example, the lignin peroxidase may be a product obtained by culturing a peptide, an extract of a tissue or cell derived from a plant, or a microorganism (eg, bacteria or fungi, and particularly yeast).
용어 "단백질(Protein)”는 아마이드 결합 (또는 펩티드 결합)으로 연결된 2개 이상의 아미노산으로 이루어진 폴리머를 의미한다.The term “protein” refers to a polymer consisting of two or more amino acids linked by amide bonds (or peptide bonds).
상기 리그닌 과산화효소는 리그닌 과산화효소의 아미노산 서열과 각각 약 70% 이상, 약 75% 이상, 약 80% 이상, 약 85%이상, 약 90% 이상, 약 92% 이상, 약 95% 이상, 약 97% 이상, 약 98% 이상, 또는 약 99% 이상의 서열 상동성을 갖는 단백질을 포함할 수 있다. 예를 들어, 상기 리그닌 과산화효소는 리그닌 과산화효소 동질효소일 수 있다. 구체적으로 상기 리그닌 과산화효소는 백색부후균(Phanerochaete chrysosporium) 유래 리그닌 과산화효소일 수 있다. 보다 구체적으로 백색부후균(Phanerochaete chrysosporium) 유래 리그닌 과산화효소 동질효소 H8(Lignin Peroxidase isozyme H8: LiPH8)일 수 있고, 이는 서열번호 1의 아미노산 서열로 이루어진 단백질일 수 있다. The lignin peroxidase is about 70% or more, about 75% or more, about 80% or more, about 85% or more, about 90% or more, about 92% or more, about 95% or more, about 97% or more of the amino acid sequence of lignin peroxidase, respectively. % Or greater, about 98% or greater, or about 99% or greater sequence homology. For example, the lignin peroxidase may be a lignin peroxidase isoenzyme. Specifically, the lignin peroxidase may be a lignin peroxidase derived from Phanerochaete chrysosporium. More specifically , it may be a lignin peroxidase isozyme H8 (LiPH8) derived from Phanerochaete chrysosporium , which may be a protein consisting of the amino acid sequence of SEQ ID NO: 1.
용어 "상동성(Homology)"은 야생형 아미노산 서열과의 유사한 정도를 나타내기 위한 것으로서, 이러한 상동성의 비교는 당업계에서 널리 알려진 비교 프로그램을 이용하여 수행할 수 있으며, 2개 이상의 서열간 상동성을 백분율(%)로 계산할 수 있다.The term "homology" is intended to indicate the degree of similarity with the wild-type amino acid sequence, and comparison of such homology can be performed using a comparison program well known in the art, and homology between two or more sequences It can be calculated as a percentage (%).
또한, 보다 나은 화학적 안정성, 강화된 약리 특성(반감기, 흡수성, 역가, 효능 등), 변경된 특이성(예를 들어, 광범위한 생물학적 활성 스펙트럼), 감소된 항원성을 획득하기 위하여, 상기 리그닌 과산화효소의 N- 또는 C-말단에 보호기가 결합되어 있을 수 있다. 상기 보호기는 아세틸기, 플루오레닐 메톡시 카르보닐기, 포르밀기, 팔미토일기, 미리스틸기, 스테아릴기 또는 폴리에틸렌글리콜(PEG)일 수 있으나, 상기 리그닌 과산화효소의 개질, 특히 리그닌 과산화효소의 안정성 증진시킬 수 있는 성분이라면, 제한없이 포함할 수 있다.In addition, in order to obtain better chemical stability, enhanced pharmacological properties (half-life, absorption, titer, efficacy, etc.), altered specificity (e.g., broad biological activity spectrum), reduced antigenicity, the N of the lignin peroxidase -Or a protecting group may be bonded to the C-terminus. The protecting group may be an acetyl group, a fluorenyl methoxycarbonyl group, a formyl group, a palmitoyl group, a myristyl group, a stearyl group, or a polyethylene glycol (PEG), but the modification of the lignin peroxidase, particularly the stability of lignin peroxidase Any ingredient that can be promoted may be included without limitation.
상기 용어 "안정성"은 생체 내 단백질 절단효소의 공격으로부터 상기 리그닌 과산화효소를 보호하는 인 비보(in vivo) 안정성 뿐만 아니라, 저장 안정성(예컨대, 상온 저장 안정성)도 의미하는 것일 수 있다. The term "stability" may mean not only in vivo stability that protects the lignin peroxidase from attack by protein cleavage enzymes in vivo, but also storage stability (eg, room temperature storage stability).
아울러, 상기 리그닌 과산화효소는 표적화 서열, 태그 (tag), 표지된 잔기를 위한 특정 목적으로 제조된 아미노산 서열도 추가적으로 포함할 수 있다.In addition, the lignin peroxidase may additionally include a targeting sequence, a tag, and an amino acid sequence prepared for a specific purpose for a labeled residue.
상기 리그닌 과산화효소의 조성물 내 농도는 0.04 U/ml 내지 0.08 U/ml, 0.05 U/ml 내지 0.08 U/ml, 0.04 U/ml 내지 0.07 U/ml, 0.05 U/ml 내지 0.07 U/ml일 수 있다.The concentration in the composition of the lignin peroxidase may be 0.04 U/ml to 0.08 U/ml, 0.05 U/ml to 0.08 U/ml, 0.04 U/ml to 0.07 U/ml, 0.05 U/ml to 0.07 U/ml. have.
또한, 상기 조성물은 베라트릴 알코올(Veratryl Alcohol) 및 과산화수소(H2O2)를 더 포함할 수 있다.In addition, the composition may further include Veratryl Alcohol and hydrogen peroxide (H 2 O 2 ).
상기 베라트릴 알코올의 조성물 내 농도는 1 mM 내지 3 mM, 1 mM 내지 2.5 mM, 1.5 mM 내지 3 mM, 1.5 mM 내지 2.5 mM, 1.75 mM 내지 3 mM, 1.75 mM 내지 2.5 mM, 1.75 mM 내지 2.25 mM, 1.5 mM 내지 2.25 mM, 1 mM 내지 2.25 mM일 수 있다.The concentration in the composition of the veratril alcohol is 1 mM to 3 mM, 1 mM to 2.5 mM, 1.5 mM to 3 mM, 1.5 mM to 2.5 mM, 1.75 mM to 3 mM, 1.75 mM to 2.5 mM, 1.75 mM to 2.25 mM , 1.5 mM to 2.25 mM, 1 mM to 2.25 mM.
상기 과산화수소의 조성물 내 농도는 200 μM 내지 300 μM, 200 μM 내지 275 μM, 225 μM 내지 300 μM, 225 μM 내지 275 μM, 240 μM 내지 300 μM, 240 μM 내지 275 μM, 240 μM 내지 260 μM, 200 μM 내지 260 μM, 225 μM 내지 260 μM일 수 있다.The concentration in the composition of hydrogen peroxide is 200 μM to 300 μM, 200 μM to 275 μM, 225 μM to 300 μM, 225 μM to 275 μM, 240 μM to 300 μM, 240 μM to 275 μM, 240 μM to 260 μM, 200 μM to 260 μM, 225 μM to 260 μM.
상기 과산화수소의 조성물 내 농도가 200 μM 미만인 경우, 리그닌 과산화효소의 비활성이 떨어짐에 따라 멜라닌 탈색 효율이 좋지 않을 수 있고, 상기 과산화수소의 조성물 내 농도가 300 μM 초과인 경우, 리그닌 과산화효소의 비활성은 우수할 수 있으나, 멜라닌 탈색 효율이 좋지 않을 수 있다.When the concentration in the composition of hydrogen peroxide is less than 200 μM, melanin decolorization efficiency may be poor as the specific activity of lignin peroxidase decreases, and when the concentration in the composition of hydrogen peroxide is more than 300 μM, the specific activity of lignin peroxidase is excellent. It can be done, but the melanin bleaching efficiency may not be good.
또한, 상기 조성물의 pH는 3.5 내지 4.5, 3.5 내지 4.25, 3.75 내지 4.5, 3.75 내지 4.25, 3.9 내지 4.5, 3.9 내지 4.25, 3.9 내지 4.1, 3.5 내지 4.1, 3.75 내지 4.1일 수 있다. In addition, the pH of the composition may be 3.5 to 4.5, 3.5 to 4.25, 3.75 to 4.5, 3.75 to 4.25, 3.9 to 4.5, 3.9 to 4.25, 3.9 to 4.1, 3.5 to 4.1, 3.75 to 4.1.
상기 조성물의 pH가 3.5 미만인 경우, 리그닌 과산화효소의 비활성(specific activity)은 우수할 수 있으나, 베라트릴 알코올 양이온 라디칼이 멜라닌과 접하지 못하며, 리그닌 과산화효소와 멜라닌이 결합되어 침전되어 멜라닌의 탈색효율이 좋지 않을 수 있다. 또한, 상기 조성물의 pH가 4.5 초과하는 경우, 리그닌 과산화효소의 비활성이 매우 떨어짐에 따라 멜라닌 탈색 효율이 좋지 않을 수 있다.When the pH of the composition is less than 3.5, the specific activity of lignin peroxidase may be excellent, but the veratryl alcohol cation radical does not come into contact with melanin, and the lignin peroxidase and melanin are combined and precipitated, resulting in melanin depigmentation efficiency. This can be bad. In addition, when the pH of the composition exceeds 4.5, melanin decolorization efficiency may not be good as the specific activity of lignin peroxidase is very low.
또한, 상기 조성물은 포도당 산화효소(Glucose Oxidase)를 더 포함할 수 있다.In addition, the composition may further include glucose oxidase.
상기 포도당 산화효소는 포도당 및 산소가 반응하여 글루콘산 및 과산화수소가 생성되는 반응을 촉매하며, 생성된 과산화수소는 상기 리그닌 과산화효소가 촉매하는 베라트릴 알코올과의 반응에 사용될 수 있다. 이 때, 포도당 및 산소의 반응을 촉매하는 포도당 산화효소를 이용한 과산화수소의 생성은 리그닌 과산화효소에 저농도로 연속적으로 공급될 수 있어, 멜라닌 탈색 효율이 매우 우수하고, 이에 따라 상기 조성물의 피부 미백 효과가 더욱 우수해질 수 있다.The glucose oxidase catalyzes the reaction of glucose and oxygen to produce gluconic acid and hydrogen peroxide, and the generated hydrogen peroxide may be used for a reaction with veratril alcohol catalyzed by the lignin peroxidase. At this time, the generation of hydrogen peroxide using glucose oxidase that catalyzes the reaction of glucose and oxygen can be continuously supplied to lignin peroxidase at low concentration, so that the melanin bleaching efficiency is very excellent, and accordingly, the skin whitening effect of the composition is It can be better.
상기 포도당 산화효소는 천연으로부터 유래될 수도 있고, 당해 분야에서 널리 공지된 다양한 단백질 합성 방법으로 획득할 수 있다. 일례로서, 폴리뉴클레오티드 재조합과 단백질 발현 시스템을 이용하여 제조하거나 단백질 합성과 같은 화학적 합성을 통하여 시험관 내에서 합성하는 방법 및 무세포 단백질 합성법 등으로 제조될 수 있다. 또한, 일례로서, 상기 포도당 산화효소는 펩티드, 식물 유래 조직이나 세포의 추출물, 미생물(예를 들어 세균류 또는 진균류, 그리고 특히 효모)의 배양으로 얻어진 생산물일 수 있다.The glucose oxidase may be derived from nature or may be obtained by various protein synthesis methods well known in the art. As an example, it may be prepared by using a polynucleotide recombination and protein expression system, or by a method of in vitro synthesis through chemical synthesis such as protein synthesis, a cell-free protein synthesis method, and the like. In addition, as an example, the glucose oxidase may be a product obtained by culturing a peptide, an extract of a plant-derived tissue or cell, or a microorganism (eg, bacteria or fungi, and particularly yeast).
상기 포도당 산화효소는 포도당 산화효소의 아미노산 서열과 각각 약 70% 이상, 약 75% 이상, 약 80% 이상, 약 85%이상, 약 90% 이상, 약 92% 이상, 약 95% 이상, 약 97% 이상, 약 98% 이상, 또는 약 99% 이상의 서열 상동성을 갖는 단백질을 포함할 수 있다. 구체적으로 상기 포도당 산화효소는 검정곰팡이(Aspergillus niger) 유래 포도당 산화 효소(Glucose Oxidase: GOx)일 수 있고, 보다 구체적으로 서열번호 2의 아미노산 서열로 이루어진 단백질일 수 있다. The glucose oxidase is about 70% or more, about 75% or more, about 80% or more, about 85% or more, about 90% or more, about 92% or more, about 95% or more, about 97% or more of the amino acid sequence of glucose oxidase, respectively. % Or greater, about 98% or greater, or about 99% or greater sequence homology. Specifically, the glucose oxidase may be a glucose oxidase (GOx) derived from black mold (Aspergillus niger ), and more specifically, may be a protein consisting of the amino acid sequence of SEQ ID NO: 2.
또한, 보다 나은 화학적 안정성, 강화된 약리 특성(반감기, 흡수성, 역가, 효능 등), 변경된 특이성(예를 들어, 광범위한 생물학적 활성 스펙트럼), 감소된 항원성을 획득하기 위하여, 상기 포도당 산화효소의 N- 또는 C-말단에 보호기가 결합되어 있을 수 있다. 상기 보호기는 아세틸기, 플루오레닐 메톡시 카르보닐기, 포르밀기, 팔미토일기, 미리스틸기, 스테아릴기 또는 폴리에틸렌글리콜(PEG)일 수 있으나, 상기 포도당 산화효소의 개질, 특히 포도당 산화효소의 안정성 증진시킬 수 있는 성분이라면, 제한없이 포함할 수 있다.In addition, in order to obtain better chemical stability, enhanced pharmacological properties (half-life, absorption, titer, efficacy, etc.), altered specificity (e.g., broad biological activity spectrum), reduced antigenicity, the N of the glucose oxidase -Or a protecting group may be bonded to the C-terminus. The protecting group may be an acetyl group, a fluorenyl methoxy carbonyl group, a formyl group, a palmitoyl group, a myristyl group, a stearyl group, or a polyethylene glycol (PEG), but the modification of the glucose oxidase, especially the stability of glucose oxidase Any ingredient that can be promoted may be included without limitation.
상기 용어 "안정성"은 생체 내 단백질 절단효소의 공격으로부터 상기 포도당 산화효소를 보호하는 인 비보(in vivo) 안정성 뿐만 아니라, 저장 안정성(예컨대, 상온 저장 안정성)도 의미하는 것일 수 있다. The term "stability" may mean not only in vivo stability that protects the glucose oxidase from attack by protein cleavage enzymes in vivo, but also storage stability (eg, room temperature storage stability).
아울러, 상기 포도당 산화효소는 표적화 서열, 태그 (tag), 표지된 잔기를 위한 특정 목적으로 제조된 아미노산 서열도 추가적으로 포함할 수 있다.In addition, the glucose oxidase may additionally include a targeting sequence, a tag, and an amino acid sequence prepared for a specific purpose for a labeled residue.
상기 포도당 산화효소의 조성물 내 농도는 0.2 U/ml 내지 0.3 U/ml, 0.2 U/ml 내지 0.275 U/ml, 0.225 U/ml 내지 0.3 U/ml, 0.225 U/ml 내지 0.275 U/ml, 0.24 U/ml 내지 0.3 U/ml, 0.24 U/ml 내지 0.275 U/ml, 0.24 U/ml 내지 0.26 U/ml, 0.2 U/ml 내지 0.26 U/ml, 0.225 U/ml 내지 0.26 U/ml일 수 있다. 상기 포도당 산화 효소의 범위 내에서 멜라닌 탈색 효율이 우수할 수 있다.The concentration in the composition of the glucose oxidase is 0.2 U/ml to 0.3 U/ml, 0.2 U/ml to 0.275 U/ml, 0.225 U/ml to 0.3 U/ml, 0.225 U/ml to 0.275 U/ml, 0.24 U/ml to 0.3 U/ml, 0.24 U/ml to 0.275 U/ml, 0.24 U/ml to 0.26 U/ml, 0.2 U/ml to 0.26 U/ml, 0.225 U/ml to 0.26 U/ml have. The melanin bleaching efficiency may be excellent within the range of the glucose oxidase.
또한, 상기 포도당은 조성물이 적용될 개체 내 존재하거나 개체 내에서 발생되는 포도당일 수 있으나, 조성물에 포함될 수도 있다.In addition, the glucose may be glucose present in or generated in the subject to which the composition is to be applied, but may be included in the composition.
용어 "개체"란 멜라닌을 보유할 수 있는 인간을 포함한 쥐, 생쥐, 가축, 세포 등의 모든 생물을 의미한다. 구체적인 예로, 인간을 포함한 포유동물일 수 있고, 인 비보(in vivo) 뿐만 아니라 인 비트로(in vitro)의 상태도 포함한다.The term "individual" refers to all organisms such as mice, mice, livestock, cells, including humans, which are capable of possessing melanin. As a specific example, it may be a mammal, including humans, and includes not only in vivo but also in vitro conditions.
상기 포도당이 조성물에 포함되어 있는 경우, 조성물 내 농도는 100 mM 내지 500 mM, 100 mM 내지 400 mM, 200 mM 내지 500 mM, 200 mM 내지 400 mM, 100 mM 내지 350 mM, 200 mM 내지 350 mM, 250 mM 내지 350 mM, 250 mM 내지 500 mM, 250 mM 내지 400 mM일 수 있다. 상기 포도당의 농도 범위 내에서 멜라닌 탈색 효율이 우수할 수 있다.When the glucose is included in the composition, the concentration in the composition is 100 mM to 500 mM, 100 mM to 400 mM, 200 mM to 500 mM, 200 mM to 400 mM, 100 mM to 350 mM, 200 mM to 350 mM, 250 mM to 350 mM, 250 mM to 500 mM, 250 mM to 400 mM. The melanin bleaching efficiency may be excellent within the concentration range of glucose.
또한, 상기 조성물은 상기 포도당 과산화효소에 추가적으로 산소(O2)를 더 포함할 수 있다. 상기 조성물의 포도당 및 포도당 산화효소는 공기 중 또는 외부의 산소와 반응하여 과산화수소를 생산할 수 있으며, 조성물 내 산소와 반응하여 과산화수소를 생산할 수도 있다.In addition, the composition may further include oxygen (O 2) in addition to the glucose peroxidase. The glucose and glucose oxidase of the composition may react with oxygen in the air or outside to produce hydrogen peroxide, and may react with oxygen in the composition to produce hydrogen peroxide.
또한, 상기 화장료 조성물은 화장료 조성물에 통상적으로 첨가되는 성분, 예컨대 항산화제, 안정화제, 가용화제, 비타민, 안료 및 향료와 같은 통상적인 보조제 및 담체를 추가적으로 포함할 수 있다. In addition, the cosmetic composition may additionally include components conventionally added to the cosmetic composition, such as antioxidants, stabilizers, solubilizers, vitamins, pigments, and conventional adjuvants and carriers such as fragrances.
상기 화장료 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어, 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클린싱, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이 등으로 제형화될 수 있으나, 이에 한정되는 것은 아니다. 보다 상세하게는, 유연 화장수 또는 영양 화장수 등과 같은 화장수, 훼이셜 로션, 바디로션 등과 같은 유액, 영양 크림, 수분 크림, 아이 크림 등과 같은 크림, 에센스, 화장연고, 스프레이, 젤, 팩, 선 스크린, 메이크업 베이스, 액체 타입, 고체 타입 또는 스프레이 타입 등의 파운데이션, 파우더 등의 제형으로 제조될 수 있다. 이 경우 상기 화장료 조성물은 유화제, 비누산, 용매, 착색제, 보존제, 항산화제, 소포제, 항균제, 항재침착제, 효소, 식물 또는 미네랄 오일, 지방, 형광물질, 살진균제, 굴수성 유발물질, 보습체, 방향제, 방향제 담체, 보존제, 단백질, 실리콘, 용해화제, 당 유도체, 일광차단제, 비타민, 식물 추출물, 왁스 등을 포함하는 부형제를 함유할 수 있다.The cosmetic composition may be prepared in any formulation conventionally prepared in the art, for example, solutions, suspensions, emulsions, pastes, gels, creams, lotions, powders, soaps, surfactant-containing cleansing, oils , Powder foundation, emulsion foundation, wax foundation, and spray may be formulated, but are not limited thereto. More specifically, lotions such as flexible lotion or nutrient lotion, emulsions such as facial lotion and body lotion, creams such as nutritional cream, moisture cream, eye cream, etc., essence, cosmetic ointment, spray, gel, pack, sunscreen, make-up It can be prepared in a formulation such as a foundation, a powder, such as a base, a liquid type, a solid type, or a spray type. In this case, the cosmetic composition is an emulsifier, a soap acid, a solvent, a colorant, a preservative, an antioxidant, an antifoaming agent, an antibacterial agent, an anti-redeposition agent, an enzyme, a plant or mineral oil, a fat, a fluorescent substance, a fungicide, a hydrophobic substance, a moisturizer, It may contain excipients including fragrances, fragrance carriers, preservatives, proteins, silicones, solubilizers, sugar derivatives, sunscreen agents, vitamins, plant extracts, waxes, and the like.
상기 화장료 조성물의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라가칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the cosmetic composition is a paste, cream or gel, animal oil, vegetable oil, wax, paraffin, starch, tragacanth, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc, or zinc oxide, etc. are used as carrier components. Can be used.
상기 화장료 조성물의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the cosmetic composition is a powder or spray, toss, talc, silica, aluminum hydroxide, calcium silicate, or polyamide powder may be used as a carrier component. In particular, in the case of a spray, additional chlorofluorohydrocarbon, Propellants such as propane/butane or dimethyl ether.
상기 화장료 조성물의 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 가용화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the cosmetic composition is a solution or emulsion, a solvent, a solubilizing agent or an emulsifying agent is used as a carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3-butylglycol oil, glycerol aliphatic ester, polyethylene glycol or fatty acid ester of sorbitan.
상기 화장료 조성물의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라가칸트 등이 이용될 수 있다.When the formulation of the cosmetic composition is a suspension, as a carrier component, a liquid diluent such as water, ethanol or propylene glycol, an ethoxylated isostearyl alcohol, a suspending agent such as polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, micro Crystalline cellulose, aluminum metahydroxide, bentonite, agar or tragacanth, and the like may be used.
다른 양상은 개체의 피부에 상기 조성물을 적용하는 단계를 포함하는 피부 내 멜라닌의 탈색 방법을 제공한다.Another aspect provides a method of depigmenting melanin in skin comprising applying the composition to the skin of a subject.
용어 "적용"은 손가락, 브러쉬, 솜뭉치, 패드, 스프레이, 스폰지, 면봉, 롤-온(roll-on) 등에 의한 적용과 같이, 개체의 피부에 투여 또는 도포하는 방법을 포함한다. 해당 분야의 통상의 기술자는 적용하는 적절한 방법을 용이하게 결정할 수 있다.The term “application” includes methods of administration or application to the skin of a subject, such as application by finger, brush, cotton ball, pad, spray, sponge, cotton swab, roll-on, and the like. A person skilled in the art can readily determine the appropriate method to apply.
상기 조성물은 전술한 범위 내의 조성물일 수 있으며, 상기 조성물을 적용을 통해 전술한 바와 같이 피부 내 멜라닌의 탈색을 통해 적용된 개체의 피부 미백 효과를 달성할 수 있다.The composition may be a composition within the above-described range, and through application of the composition, the skin whitening effect of the applied individual may be achieved through decolorization of melanin in the skin as described above.
또 다른 양상은 개체의 피부에 리그닌 과산화효소, 베라트릴 알코올 및 과산화수소를 적용하는 단계를 포함하는 피부 내 멜라닌의 탈색 방법을 제공한다.Another aspect provides a method for depigmenting melanin in skin comprising applying lignin peroxidase, veratrile alcohol, and hydrogen peroxide to the skin of an individual.
상기 "리그닌 과산화효소", "베라트릴 알코올", "과산화수소" 등은 전술한 범위 내일 수 있다.The "lignin peroxidase", "veratryl alcohol", "hydrogen peroxide" and the like may be within the above-described range.
상기 피부 내 멜라닌의 탈색 방법에 있어서, 상기 과산화수소의 적용은 80 μM 내지 300 μM의 과산화수소 용액을 적용하는 것일 수 있다.In the method of bleaching melanin in the skin, the application of the hydrogen peroxide may be applying a hydrogen peroxide solution of 80 μM to 300 μM.
상기 과산화수소 용액은 용질로서 과산화수소를 포함하고 있는 용액을 의미하며, 상기 용액의 용매에는 제한되지 않으나, 예를 들어, 물일 수 있고, 구체적으로 증류수일 수 있고, 보다 구체적으로 3차 증류수일 수 있다.The hydrogen peroxide solution refers to a solution containing hydrogen peroxide as a solute, and the solvent of the solution is not limited, but may be water, specifically distilled water, and more specifically tertiary distilled water.
상기 과산화수소 용액의 농도는 80 μM 내지 300 μM, 100 μM 내지 300 μM, 80 μM 내지 250 μM, 100 μM 내지 250 μM, 80 μM 내지 200 μM, 100 μM 내지 200 μM, 150 μM 내지 200 μM, 150 μM 내지 300 μM, 150 μM 내지 250 μM일 수 있다.The concentration of the hydrogen peroxide solution is 80 μM to 300 μM, 100 μM to 300 μM, 80 μM to 250 μM, 100 μM to 250 μM, 80 μM to 200 μM, 100 μM to 200 μM, 150 μM to 200 μM, 150 μM To 300 μM, 150 μM to 250 μM.
또한, 상기 피부 내 멜라닌의 탈색 방법에 있어서, 상기 과산화수소의 적용은 과산화수소 용액을 1분 내지 90분의 간격으로 적용하는 것일 수 있고, 구체적으로 1분 내지 90분, 5분 내지 90분, 1분 내지 60분, 5분 내지 60분, 1분 내지 30분, 5분 내지 30분, 10분 내지 30분, 10분 내지 90분, 10분 내지 60분의 간격으로 이루어지는 것일 수 있다.In addition, in the method of bleaching melanin in the skin, the application of the hydrogen peroxide may be to apply a hydrogen peroxide solution at intervals of 1 minute to 90 minutes, specifically 1 minute to 90 minutes, 5 minutes to 90 minutes, 1 minute It may be made at intervals of to 60 minutes, 5 minutes to 60 minutes, 1 minute to 30 minutes, 5 minutes to 30 minutes, 10 minutes to 30 minutes, 10 minutes to 90 minutes, and 10 minutes to 60 minutes.
또한, 상기 피부 내 멜라닌의 탈색 방법에 있어서, 상기 과산화수소의 적용은 상기 과산화수소의 적용은 과산화수소 용액을 1회 내지 30회로 적용하는 것일 수 있고, 구체적으로 1회 내지 30회, 1회 내지 25회, 5회 내지 30회, 5회 내지 25회, 1회 내지 20회, 5회 내지 20회, 10회 내지 20회, 10회 내지 30회, 10회 내지 25회로 적용되는 것일 수 있다.In addition, in the method of bleaching melanin in the skin, the application of the hydrogen peroxide may be the application of the hydrogen peroxide solution 1 to 30 times, specifically 1 to 30 times, 1 to 25 times, It may be applied 5 to 30 times, 5 to 25 times, 1 to 20 times, 5 to 20 times, 10 to 20 times, 10 to 30 times, 10 to 25 times.
전술한 바와 같이 리그닌 과산화효소는 베라트릴 알코올 및 과산화수소가 반응하여 베라트릴 알코올 양이온 라디칼 및 물을 생성시키는 반응을 촉매한다. 상기 베라트릴 알코올 양이온 라디칼은 피부 내 멜라닌과 작용하여 멜라닌을 탈색시킬 수 있다. 이를 통해 적용된 개체의 피부 미백 효과를 달성할 수 있다.As described above, lignin peroxidase catalyzes the reaction of veratryl alcohol and hydrogen peroxide to produce veratryl alcohol cation radicals and water. The veratryl alcohol cation radical may decolorize melanin by acting with melanin in the skin. Through this, it is possible to achieve the skin whitening effect of the applied object.
리그닌 과산화효소(Lignin Peroxidase)를 포함하는 피부 미백용 화장료 조성물은 피부 부작용이 매우 적으며, 멜라닌을 선택적으로 탈색할 뿐만 아니라 멜라닌 탈색 효율이 우수하다. 나아가, 포도당 산화효소를 포함하는 조성물의 경우, 저농도의 과산화수소의 연속적인 공급을 통해 멜라닌의 탈색 효율이 더욱 증진되므로, 상기 조성물을 피부 미백용도로 이용할 수 있다.A cosmetic composition for skin whitening containing lignin peroxidase has very few skin side effects, selectively bleaching melanin, and excellent melanin bleaching efficiency. Further, in the case of a composition containing glucose oxidase, since the decolorization efficiency of melanin is further enhanced through continuous supply of low concentration hydrogen peroxide, the composition can be used for skin whitening.
또한, 상기 조성물을 이용한 피부 내 멜라닌의 탈색 방법 또한, 멜라닌을 선택적으로 탈색시키며, 그 효율이 우수하여 적용된 개체의 피부 미백 효과를 달성할 수 있다.In addition, the method of decolorizing melanin in the skin using the composition also selectively decolorizes melanin, and its efficiency is excellent, so that the skin whitening effect of the applied individual can be achieved.
도 1은 리그닌 과산화효소에 의한 멜라닌 탈색의 기전 설명에 관한 것으로, (a)는 산화 환원 매개체인 VA 양이온 라디칼을 이용하여 리그닌 과산화효소가 촉매 작용을 하는 멜라닌 탈색 기전을 나타낸 도이고, (b)는 포도당 산화 효소에 의해 발생된 H2O2로 리그닌 과산화효소 촉매 멜라닌 탈색 기전을 나타낸 도이다.
도 2는 veratryl alcohol을 이용한 pH 의존적 멜라닌 탈색 효율 및 LiPH8의 특이적 활성을 나타낸 도이다.
도 3은 veratryl alcohol에 대한 멜라닌의 탈색 효율과 LiPH8의 활성에 미치는 H2O2 농도의 영향을 나타낸 도이다.
도 4는 간헐적으로 H2O2를 첨가하여 일어나는 멜라닌 탈색 반응을 나타낸 도이다.
도 5는 GOX와 함께 촉매된 LiPH에 의한 시간에 따른 멜라닌 탈색 효율을 나타낸 도이다.1 is a diagram illustrating the mechanism of melanin decolorization by lignin peroxidase, (a) is a diagram showing the melanin decolorization mechanism in which lignin peroxidase catalyzes a catalytic action using VA cationic radicals, which are redox mediators, (b) Is a diagram showing the mechanism of melanin decolorization catalyzed by lignin peroxidase with H 2 O 2 generated by glucose oxidase.
2 is a diagram showing the pH-dependent melanin bleaching efficiency and specific activity of LiPH8 using veratryl alcohol.
3 is a diagram showing the effect of H 2 O 2 concentration on the bleaching efficiency of melanin and the activity of LiPH8 for veratryl alcohol.
4 is a diagram showing a melanin decolorization reaction occurring by intermittently adding H 2 O 2.
5 is a diagram showing the melanin decolorization efficiency over time by LiPH catalyzed with GO X.
이하 본 발명을 실시예를 통하여 보다 상세하게 설명한다. 그러나, 이들 실시예는 본 발명을 예시적으로 설명하기 위한 것으로 본 발명의 범위가 이들 실시예에 한정되는 것은 아니다. Hereinafter, the present invention will be described in more detail through examples. However, these examples are for illustrative purposes only, and the scope of the present invention is not limited to these examples.
실시예Example
실시예 1. 재조합 리그닌 과산화효소의 생산 및 분리 정제 Example 1. Production and separation and purification of recombinant lignin peroxidase
백색부후균(Phanerochaete chrysosporium) 유래 리그닌 과산화효소 동질효소 H8(Lignin Peroxidase isozyme H8: LiPH8, 서열번호 1)를 암호화하는 합성 유전자는 Bioneer 회사(한국)을 통해 준비하였다(유전자 및 단백질의 염기 서열은 UniPortKB entry: P06181에 나타나 있음). 리폴딩 및 정제 방법은 이전에 발표된 논문을 준용하였다(W.A. Doyle, A.T. Smith, Expression of lignin peroxidase H8 in Escherichia coli: folding and activation of the recombinant enzyme with Ca2+ and haem, Biochem J 315(1) (1996) 15-19.).The synthetic gene encoding the lignin peroxidase isozyme H8 (Lignin Peroxidase isozyme H8: LiPH8, SEQ ID NO: 1) derived from Phanerochaete chrysosporium was prepared by Bioneer (Korea) (gene and protein base sequences are UniPortKB. entry: shown in P06181). The refolding and purification method applied mutatis mutandis to the previously published paper (WA Doyle, AT Smith, Expression of lignin peroxidase H8 in Escherichia coli: folding and activation of the recombinant enzyme with Ca 2+ and haem, Biochem J 315(1). (1996) 15-19.).
실시예 2. 리그닌 과산화효소 활성에 대한 최적 pH 조건의 결정Example 2. Determination of optimal pH conditions for lignin peroxidase activity
리그닌 과산화효소는 베라트릴 알코올(Veratryl Alcohol: VA)를 VA 양이온 라디칼(VAㆍ+)로 산화시키고, 이는 멜라닌을 탈색시키는 산화 환원 매개체로서 작용한다(도 1(a)). VA는 백색부후균류에서 생산된 천연 화합물로서, 합성 매개체보다 잠재적인 부작용이 적으므로, VA를 이용하는 리그닌 과산화효소를 사용하였고, 본 실시예에서는 멜라닌의 LiPH8 촉매 탈색에 대한 pH 효과를 조사하였다. Lignin peroxidase oxidizes Veratryl Alcohol (VA) to VA cationic radicals (VA · + ), which acts as a redox mediator to decolorize melanin (Fig. 1(a)). Since VA is a natural compound produced from white rot fungi and has fewer potential side effects than synthetic mediators, lignin peroxidase using VA was used, and in this example, the pH effect on LiPH8 catalyzed decolorization of melanin was investigated.
구체적으로, 멜라닌의 탈색은 50 mg/L 합성 멜라닌, 2 mM veratryl alcohol, 250 μM H2O2 및 0.06 U/ml LiPH8 BR 완충액에서 1시간 동안 수행하였고, 효소의 활성은 2 mM veratryl alcohol, BR 완충액 내 250 μM H2O2를 사용하여 측정하였다.Specifically, melanin bleaching was performed for 1 hour in 50 mg/L synthetic melanin, 2 mM veratryl alcohol, 250 μM H 2 O 2 and 0.06 U/ml LiPH8 BR buffer, and the enzyme activity was 2 mM veratryl alcohol, BR Measurements were made using 250 μM H 2 O 2 in buffer.
그 결과, LiPH8은 도 2에 나타낸 바와 같이 산성 조건(pH 3.0) 하에서 VA에 대해 가장 높은 비활성(specific activity)을 나타내었다. 그러나 pH 3 완충액에서 멜라닌 탈색이 일어나지 않고, 멜라닌 침전이 나타났다. 또한, 이러한 멜라닌 침전물의 형성은 효소가 첨가됨으로써 가속화되었다. 이는 고체 멜라닌과 효소 사이의 복합체 형성이 일어났다는 것을 의미한다. 따라서, 멜라닌의 적절한 탈색을 위해서는 멜라닌과 산화 환원 매개체 사이의 직접적인 접촉이 중요한 것을 알 수 있었다. 산화 환원 매개체인 VA 양이온 라디칼은 매우 짧은 수명을 갖기 때문에 멜라닌과 VA 양이온 라디칼 사이의 직접적인 접촉이 없으면 멜라닌의 탈색이 이루어지지 않는다는 것을 알 수 있었다.As a result, LiPH8 showed the highest specific activity for VA under acidic conditions (pH 3.0) as shown in FIG. 2. However, melanin decolorization did not occur in the pH 3 buffer solution, and melanin precipitation appeared. In addition, the formation of these melanin precipitates was accelerated by the addition of enzymes. This means that the formation of a complex between the solid melanin and the enzyme took place. Therefore, it was found that direct contact between melanin and a redox mediator is important for proper decolorization of melanin. Since VA cation radicals, which are redox mediators, have a very short lifespan, it was found that melanin decolorization does not occur if there is no direct contact between melanin and VA cation radicals.
또한, pH 4.0에서 LiPH8은 1시간 내에 30% 이상의 가장 높은 멜라닌 탈색 효율을 나타냈고, LiPH8은 pH 5.0 및 6.0에서 멜라닌 탈색 효율이 감소한 반면, LiPH8의 비활성은 pH 4.0에 비해 현저하게 감소된 것을 확인할 수 있었다. 결론적으로, LiPH8의 멜라닌 탈색 효율은 pH 4.0에서 가장 높다는 것을 알 수 있었고, 이후의 모든 멜라닌 탈색 반응은 pH 4.0 완충액에서 수행하였다.In addition, LiPH8 at pH 4.0 showed the highest melanin bleaching efficiency of 30% or more within 1 hour, and LiPH8 decreased melanin bleaching efficiency at pH 5.0 and 6.0, whereas the specific activity of LiPH8 was significantly reduced compared to pH 4.0. Could. In conclusion, it was found that the melanin decolorization efficiency of LiPH8 was highest at pH 4.0, and all subsequent melanin decolorization reactions were performed in pH 4.0 buffer.
실시예 3. 최적의 과산화수소 농도 및 주입 방식의 결정Example 3. Determination of Optimal Hydrogen Peroxide Concentration and Injection Method
도 1(a)에 나타난 바와 같이 리그닌 과산화효소는 VA와 과산화수소가 반응하여 물과 VA 양이온 라디칼로 생성되는 반응을 촉매한다. 따라서, 리그닌 과산화효소의 멜라닌 탈색 반응은 과산화수소를 필요로 하나, 리그닌 과산화효소는 헴 구조의 파열 또는 비활성 compound III의 형성을 통해 과도한 농도의 H2O2에 의하여 쉽게 불활성화되기도 한다. 이에, 본 실시예는 멜라닌 탈색 반응의 높은 효율을 얻기 위한 리그닌 과산화효소의 기질인 과산화수소의 최적의 농도를 파악하기 위해 수행되었다.As shown in Fig. 1(a), lignin peroxidase catalyzes the reaction of VA and hydrogen peroxide to form water and VA cation radicals. Therefore, the melanin decolorization reaction of lignin peroxidase requires hydrogen peroxide, but lignin peroxidase is easily inactivated by excessive concentration of H 2 O 2 through rupture of heme structure or formation of inactive compound III. Accordingly, this example was carried out to determine the optimal concentration of hydrogen peroxide, which is a substrate of lignin peroxidase for obtaining high efficiency of melanin decolorization reaction.
구체적으로, 멜라닌의 탈색은 50 mg/L 합성 멜라닌, 2 mM veratryl alcohol 및 0.06 U/ml LiPH8 BR 완충액(pH 4.0)에서 1시간 동안 수행하였고, 효소의 활성은 BR 완충액(pH 3.0) 내 2 mM veratryl alcohol로 측정하였다.Specifically, melanin bleaching was performed for 1 hour in 50 mg/L synthetic melanin, 2 mM veratryl alcohol, and 0.06 U/ml LiPH8 BR buffer (pH 4.0), and the activity of the enzyme was 2 mM in BR buffer (pH 3.0). It was measured with veratryl alcohol.
그 결과, 비록 H2O2가 멜라닌 탈색 동안 최종 전자 수용체로서 필수적인 기질임에도 불구하고, 멜라닌 탈색 효율은 H2O2 농도가 증가함에 따라 점차적으로 감소하며, 250 μM H2O2에서 30% 이상의 최고 수준에 근접했다. 그러나, VA에 대한 초기 비활성은 H2O2 농도가 높을수록 꾸준히 증가하였다(도 3).As a result, although H 2 O 2 is an essential substrate as the final electron acceptor during melanin decolorization, the melanin decolorization efficiency gradually decreases with increasing H 2 O 2 concentration, and more than 30% in 250 μM H 2 O 2 It was close to the highest level. However, the initial specific activity for VA steadily increased as the H 2 O 2 concentration increased (FIG. 3).
이는 H2O2가 단기간의 효소활성도(1분 이내)에는 중요한 기질이나, 장기간 반응 시(1시간 이내)에는 도리어 효소의 활성을 억제하였다는 것을 의미한다. 높은 멜라닌 탈색 효율을 위해서는 역설적으로 동시에 효소의 억제제로 작용할 수 있음에도 불구하고 높은 농도의 H2O2가 필요하므로, 전체 멜라민 탈색 효율을 향상시키는 저농도의 H2O2의 연속적인 공급을 생각할 수 있었다.This means that H 2 O 2 is an important substrate for short-term enzyme activity (within 1 minute), but inhibited enzyme activity during long-term reaction (within 1 hour). For high melanin bleaching efficiency, although it can act as an enzyme inhibitor at the same time paradoxically, a high concentration of H 2 O 2 is required, so it was possible to conceive of a continuous supply of low concentration H 2 O 2 that improves the overall melamine bleaching efficiency. .
지속적인 H2O2 공급에 의한 낮은 수준의 H2O2 유지가 멜라닌 탈색 효율을 향상시킬 수 있는지 확인하기 위해 H2O2의 간헐적 첨가를 수행하였다. 도 3에 도시된 결과에 기초하여, LiPH8을 불활성화시킬 수 있는 H2O2의 임계 농도는 300 내지 350μM으로 가정하였다. 구체적으로, 멜라닌의 탈색은 pH 4.0의 BR 완충액에서 합성 멜라닌 50 mg/L, veratryl alcohol 2 mM 및 LiPH8 0.06 U/ml로 수행하였다.Intermittent addition of H 2 O 2 was performed to confirm whether maintenance of low level H 2 O 2 by continuous H 2 O 2 supply can improve melanin decolorization efficiency. Based on the results shown in FIG. 3, the critical concentration of H 2 O 2 capable of inactivating LiPH8 was assumed to be 300 to 350 μM. Specifically, melanin decolorization was performed with 50 mg/L of synthetic melanin, 2 mM veratryl alcohol, and 0.06 U/ml of LiPH8 in BR buffer at pH 4.0.
총 H2O2를 1시간 내에 60, 30, 20, 15 및 12 분 간격으로 균등하게 나누어 공급하였는데, 이는 구체적으로 총 반응 부피 2 ml 기준으로, 과산화수소 용액이 총 10 μl 공급되었다. 과산화수소 용액은 30% 과산화수소 (9.8 M)를 3차 증류수에 희석해서 사용하였다. 과산화수소 용액은 3차 증류수에 반응 농도의 200배 (1200 μM의 경우 240 mM)로 준비하였다. 1회당 공급되는 과산화수소의 부피는 공급 시간 간격마다 다른데, 60분 간격의 경우 1회 공급되므로 1회당 10 μl, 30분 간격의 경우 2회 공급되므로 1회당 5 μl, 20분 간격의 경우 3회 공급되므로 1회당 3.33 μl, 15분 간격의 경우 4회 공급되므로 1회당 2.5 μl, 12분 간격의 경우 5회 공급되므로 1회당 2 μl 씩 공급하였다.Total H 2 O 2 was evenly divided and supplied at intervals of 60, 30, 20, 15 and 12 minutes within 1 hour, specifically, based on a total reaction volume of 2 ml, a total of 10 μl of a hydrogen peroxide solution was supplied. The hydrogen peroxide solution was used by diluting 30% hydrogen peroxide (9.8 M) in tertiary distilled water. The hydrogen peroxide solution was prepared in tertiary distilled water at 200 times the reaction concentration (240 mM in the case of 1200 μM). The volume of hydrogen peroxide supplied per time is different for each supply time interval.In the case of 60 minutes, it is supplied once, so 10 μl is supplied per time, and in the case of 30 minutes, it is supplied twice, so it is supplied 5 μl per time, and in the case of 20 minute intervals, it is supplied 3 times. Therefore, 3.33 μl was supplied per once, and 2.5 μl was supplied four times in the case of 15-minute intervals, and 2 μl was supplied per time because it was supplied five times in the case of 12-minute intervals.
그 결과, H2O2 농도가 1400 μM이고 시간 간격이 12분인 경우, 순간 H2O2 농도가 280 μM에 불과 함에도 불구하고 억제 효과가 관찰되었다(도 4). 본 실시예에서 첨가된 LiPH8은 12분 이내에 280 μM의 H2O2를 소비하기에 충분하지 않았을 것으로 생각되었다. 그럼에도 불구하고 멜라닌 탈색 효율은 약 1000 μM 및 1200 μM H2O2에서 포화되어 70%에 다다랐기 때문에 12분당 280 μM의 H2O2를 소비할지라도 더 많은 효소를 첨가하는 것은 효율적이지 않았다. 이를 제외하고는 300 μM 미만의 H2O2의 순간 농도는 멜라닌 탈색에 대한 어떠한 억제 효과도 나타내지 않았다.As a result, when the H 2 O 2 concentration was 1400 μM and the time interval was 12 minutes , the inhibitory effect was observed even though the instant H 2 O 2 concentration was only 280 μM (FIG. 4). It was thought that the LiPH8 added in this example was not sufficient to consume 280 μM of H 2 O 2 within 12 minutes. Nevertheless, melanin decolorization efficiency reached 70% saturated at about 1000 μM and 1200 μM H 2 O 2 , so even though 280 μM of H 2 O 2 was consumed per 12 minutes, it was not efficient to add more enzymes. Except for this, the instantaneous concentration of H 2 O 2 less than 300 μM did not show any inhibitory effect on melanin decolorization.
이는 과도한 H2O2로 인한 LiPH8의 불활성화를 억제함으로써 멜라닌 색소 탈색을 개선시키는데 일정 시간 간격으로 H2O2를 간헐적으로 공급하는 것이 매우 효과적이라는 것을 나타내었다. 그러나 미백용 화장품의 경우, 시간 간격에 따라 간헐적으로 H2O2를 공급하는 것이 거의 불가능하며, 이는 LiPH8에 대해 저농도의 H2O2를 동시에 연속적으로 생성할 필요가 있음을 의미한다.This indicated that intermittent supply of H 2 O 2 at regular time intervals was very effective in improving melanin pigment bleaching by inhibiting the inactivation of LiPH8 due to excessive H 2 O 2. However, in the case of whitening cosmetics, it is almost impossible to supply H 2 O 2 intermittently according to time intervals, which means that it is necessary to continuously and simultaneously generate low concentration H 2 O 2 for LiPH8.
실시예 4. 포도당 산화효소(Glucose Oxidase:GOx)에 의한 과산화수소 생산을 위한 최적 포도당 산화효소 활성 결정Example 4. Determination of optimal glucose oxidase activity for hydrogen peroxide production by glucose oxidase (GOx)
본 실시예에서는 연속적인 저농도의 H2O2의 in-situ 생성을 위해 분자 O2를 사용하여 β-D-포도당의 산화를 촉매하여 D-글루콘산과 H2O2를 생산하는 검정곰팡이(Aspergillus niger) 유래 포도당 산화 효소(Glucose Oxidase: GOx, Sigma Aldrich, #G6766, 서열번호 2)(유전자 및 단백질의 염기 서열은 UniPortKB entry: P13006에 나타나 있음)를 사용하였다. 생성된 H2O2는 전자 수용체로서 멜라닌을 탈색시키기 위해 리그닌 과산화효소에 의해 이용되었다(도 1(b)).In this example, a black mold producing D-gluconic acid and H 2 O 2 by catalyzing the oxidation of β-D-glucose by using the molecule O 2 for continuous in-situ generation of low concentration H 2 O 2 ( Aspergillus niger ) derived glucose oxidase (Glucose Oxidase: GOx, Sigma Aldrich, #G6766, SEQ ID NO: 2) (gene and protein nucleotide sequences are shown in UniPortKB entry: P13006) was used. The generated H 2 O 2 was used by lignin peroxidase to decolor melanin as an electron acceptor (Fig. 1(b)).
구체적으로, 멜라닌의 탈색은 pH 4.0의 BR 완충액에서 합성 멜라닌 50 mg/L, veratryl alcohol 2 mM, LiPH8 0.06 U/ml로 수행하였다.Specifically, melanin decolorization was performed with 50 mg/L of synthetic melanin, 2 mM veratryl alcohol, and 0.06 U/ml of LiPH8 in BR buffer at pH 4.0.
그 결과, GOx는 또한 pH 4.0 ~ 7.0에서 활성을 유지했는데, 이는 pH 4.0에서 멜라닌 탈색에 적용 가능하다는 것을 의미한다. 필요한 GOx의 최적 양은 표 1에 나타낸 바와 같이 다양한 GOx 단위로 멜라닌 탈색 효율에 의해 결정하였다. GOx의 단위가 증가함에 따라 탈색 효율이 비례하여 증가했다. 그러나, GOx의 첨가없이, LiPH8은 멜라닌 탈색에 대한 어떠한 활성도 나타내지 않았다(표 1). 이러한 결과는 GOX가 LiPH8 촉매 멜라닌 탈색에 필수적인 H2O2를 공급하고 있다는 것을 분명하게 나타낸다.As a result, GOx also retained its activity at pH 4.0-7.0, which means that it is applicable to melanin decolorization at pH 4.0. The optimal amount of GOx required was determined by the melanin bleaching efficiency in various GOx units as shown in Table 1. As the unit of GOx increased, the bleaching efficiency increased proportionally. However, without the addition of GOx, LiPH8 did not show any activity against melanin decolorization (Table 1). These results clearly indicate that GO X supplies H 2 O 2, which is essential for LiPH8 catalyzed melanin decolorization.
실시예 5. 포도당 산화효소에 의한 과산화수소 생산을 위한 최적 포도당 농도 결정Example 5. Determination of Optimal Glucose Concentration for Hydrogen Peroxide Production by Glucose Oxidase
생성된 H2O2의 양은 고정된 GOx 농도에 의해 사용된 포도당 농도에 의존하기 때문에 본 실시예에서는 멜라닌 탈색을 초기 포도당 농도를 변화시키면서 수행하였고, 구체적으로 멜라닌의 탈색은 pH 4.0의 BR 완충액에서 합성 멜라닌 50 mg/L, veratryl alcohol 2 mM, LiPH8 0.06 U/ml 및 0.24 U/ml 포도당 산화 효소로 수행하였다. 또한, 고농도의 포도당이 과산화수소를 고농도로 생성할 수 있으므로, 포도당 농도를 0 내지 300 mM까지 테스트하였다. 구입한 포도당 산화효소의 특성 중 Km 수치가 30 ~ 100 mM이었고, 일반적으로 Km 수치의 3배 만큼 기질을 넣으면 최대 활성이 유지되는 것으로 알려져 있어, 최대치인 300 mM까지 테스트하였다. Since the amount of H 2 O 2 produced depends on the glucose concentration used by the fixed GOx concentration, in this example, melanin decolorization was performed while changing the initial glucose concentration. Specifically, melanin decolorization was performed in the BR buffer solution at pH 4.0.
그 결과, 포도당의 농도가 증가함에 따라 멜라닌 탈색 효율이 증가하였고, 약 100 mM의 포도당 농도에서 포화된 것으로 나타났다(표 2). 그러나 1 mM 미만의 매우 낮은 포도당 농도에서 멜라닌 색소 제거 효율은 음의 값을 나타내었고, 이는 멜라닌 색소의 색이 멜라닌의 불충분한 산화로 인해 진하게 되었음을 의미한다. 또한, 최적 GOx 농도는 0.24 U/ml였고(표 1), 최적의 포도당 농도는 100 mM 내지 300 mM임을 알 수 있었다(표 2). 이는 충분한 양의 GOx와 포도당이 멜라닌 탈색에서 다른 영향을 일으키지 않았기 때문이다.As a result, as the concentration of glucose increased, the melanin bleaching efficiency increased, and it was found to be saturated at a glucose concentration of about 100 mM (Table 2). However, at a very low glucose concentration of less than 1 mM, the melanin pigment removal efficiency was negative, which means that the color of the melanin pigment became dark due to insufficient oxidation of melanin. In addition, the optimal GOx concentration was 0.24 U/ml (Table 1), and it was found that the optimal glucose concentration was 100 mM to 300 mM (Table 2). This is because sufficient amounts of GOx and glucose did not cause other effects in melanin depigmentation.
실시예 6. 포도당 산화효소 및 재조합 리그닌 과산화효소 이용 반응시간에 따른 멜라닌 탈색 Example 6. Melanin bleaching according to reaction time using glucose oxidase and recombinant lignin peroxidase
본 실시예에서는 멜라닌 탈색을 위한 최적의 포도당 산화효소 및 포도당 농도로 멜라닌 탈색을 실시하였다.In this example, melanin bleaching was performed at an optimal glucose oxidase and glucose concentration for melanin bleaching.
구체적으로, 멜라닌의 탈색은 pH 4.0의 BR 완충액에서 합성 멜라닌 50 mg/L, veratryl alcohol 2 mM, LiPH8 0.06 U/ml, 300 mM β-D-glucose 및 0.24 U/ml 포도당 산화 효소로 수행하였다.Specifically, melanin decolorization was performed with
그 결과, 멜라닌 탈색 효율은 도 5에서 나타낸 바와 같이 멜라닌 용액의 색이 시간이 지남에 따라 분명히 밝아지며, 점차적으로 증가하였다(도 5의 사진들은 왼쪽에서부터 0, 10, 20, 30, 40, 50, 60분 후 반응 용액의 사진이다). 총 40%의 멜라닌 색소 제거 효율이 20분 이내에 달성되었으며, 전체 효율은 1시간에 약 60%에 도달했다. 20분 후에 멜라닌 농도가 낮기 때문에 탈색 속도가 느려지더라도 효소는 23시간 후 80%를 달성하기에 충분한 활성을 보였다. 이는 GOX에 의한 H2O2의 생성이 LiPH8의 활성을 유지하는데 매우 효과적임을 나타낸다.As a result, the melanin decolorization efficiency was clearly brightened and gradually increased as the color of the melanin solution passed over time as shown in FIG. 5 (the photos in FIG. 5 are 0, 10, 20, 30, 40, 50 from the left. , Is a photo of the reaction solution after 60 minutes). A total of 40% melanin pigment removal efficiency was achieved within 20 minutes, and the overall efficiency reached about 60% in 1 hour. The enzyme showed sufficient activity to achieve 80% after 23 hours even though the rate of bleaching was slow because the melanin concentration was low after 20 minutes. This indicates that the production of H 2 O 2 by GO X is very effective in maintaining the activity of LiPH8.
<110> ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY <120> COSMETIC COMPOSITION FOR SKIN WHITENING COMPRISING LIGNIN PEROXIDASE AND DECOLORIZING METHOD OF MELANIN IN SKIN USING THE SAME <130> UTP19140KR <160> 2 <170> KoPatentIn 3.0 <210> 1 <211> 372 <212> PRT <213> Phanerochaete chrysosporium <220> <221> MISC_FEATURE <222> (1)..(372) <223> Lignin Peroxidase isozyme H8 <400> 1 Met Ala Phe Lys Gln Leu Phe Ala Ala Ile Ser Leu Ala Leu Leu Leu 1 5 10 15 Ser Ala Ala Asn Ala Ala Ala Val Ile Glu Lys Arg Ala Thr Cys Ser 20 25 30 Asn Gly Lys Thr Val Gly Asp Ala Ser Cys Cys Ala Trp Phe Asp Val 35 40 45 Leu Asp Asp Ile Gln Gln Asn Leu Phe His Gly Gly Gln Cys Gly Ala 50 55 60 Glu Ala His Glu Ser Ile Arg Leu Val Phe His Asp Ser Ile Ala Ile 65 70 75 80 Ser Pro Ala Met Glu Ala Gln Gly Lys Phe Gly Gly Gly Gly Ala Asp 85 90 95 Gly Ser Ile Met Ile Phe Asp Asp Ile Glu Thr Ala Phe His Pro Asn 100 105 110 Ile Gly Leu Asp Glu Ile Val Lys Leu Gln Lys Pro Phe Val Gln Lys 115 120 125 His Gly Val Thr Pro Gly Asp Phe Ile Ala Phe Ala Gly Arg Val Ala 130 135 140 Leu Ser Asn Cys Pro Gly Ala Pro Gln Met Asn Phe Phe Thr Gly Arg 145 150 155 160 Ala Pro Ala Thr Gln Pro Ala Pro Asp Gly Leu Val Pro Glu Pro Phe 165 170 175 His Thr Val Asp Gln Ile Ile Asn Arg Val Asn Asp Ala Gly Glu Phe 180 185 190 Asp Glu Leu Glu Leu Val Trp Met Leu Ser Ala His Ser Val Ala Ala 195 200 205 Val Asn Asp Val Asp Pro Thr Val Gln Gly Leu Pro Phe Asp Ser Thr 210 215 220 Pro Gly Ile Phe Asp Ser Gln Phe Phe Val Glu Thr Gln Leu Arg Gly 225 230 235 240 Thr Ala Phe Pro Gly Ser Gly Gly Asn Gln Gly Glu Val Glu Ser Pro 245 250 255 Leu Pro Gly Glu Ile Arg Ile Gln Ser Asp His Thr Ile Ala Arg Asp 260 265 270 Ser Arg Thr Ala Cys Glu Trp Gln Ser Phe Val Asn Asn Gln Ser Lys 275 280 285 Leu Val Asp Asp Phe Gln Phe Ile Phe Leu Ala Leu Thr Gln Leu Gly 290 295 300 Gln Asp Pro Asn Ala Met Thr Asp Cys Ser Asp Val Ile Pro Gln Ser 305 310 315 320 Lys Pro Ile Pro Gly Asn Leu Pro Phe Ser Phe Phe Pro Ala Gly Lys 325 330 335 Thr Ile Lys Asp Val Glu Gln Ala Cys Ala Glu Thr Pro Phe Pro Thr 340 345 350 Leu Thr Thr Leu Pro Gly Pro Glu Thr Ser Val Gln Arg Ile Pro Pro 355 360 365 Pro Pro Gly Ala 370 <210> 2 <211> 605 <212> PRT <213> Aspergillus niger <220> <221> MISC_FEATURE <222> (1)..(605) <223> Glucose Oxidase <400> 2 Met Gln Thr Leu Leu Val Ser Ser Leu Val Val Ser Leu Ala Ala Ala 1 5 10 15 Leu Pro His Tyr Ile Arg Ser Asn Gly Ile Glu Ala Ser Leu Leu Thr 20 25 30 Asp Pro Lys Asp Val Ser Gly Arg Thr Val Asp Tyr Ile Ile Ala Gly 35 40 45 Gly Gly Leu Thr Gly Leu Thr Thr Ala Ala Arg Leu Thr Glu Asn Pro 50 55 60 Asn Ile Ser Val Leu Val Ile Glu Ser Gly Ser Tyr Glu Ser Asp Arg 65 70 75 80 Gly Pro Ile Ile Glu Asp Leu Asn Ala Tyr Gly Asp Ile Phe Gly Ser 85 90 95 Ser Val Asp His Ala Tyr Glu Thr Val Glu Leu Ala Thr Asn Asn Gln 100 105 110 Thr Ala Leu Ile Arg Ser Gly Asn Gly Leu Gly Gly Ser Thr Leu Val 115 120 125 Asn Gly Gly Thr Trp Thr Arg Pro His Lys Ala Gln Val Asp Ser Trp 130 135 140 Glu Thr Val Phe Gly Asn Glu Gly Trp Asn Trp Asp Asn Val Ala Ala 145 150 155 160 Tyr Ser Leu Gln Ala Glu Arg Ala Arg Ala Pro Asn Ala Lys Gln Ile 165 170 175 Ala Ala Gly His Tyr Phe Asn Ala Ser Cys His Gly Val Asn Gly Thr 180 185 190 Val His Ala Gly Pro Arg Asp Thr Gly Asp Asp Tyr Ser Pro Ile Val 195 200 205 Lys Ala Leu Met Ser Ala Val Glu Asp Arg Gly Val Pro Thr Lys Lys 210 215 220 Asp Phe Gly Cys Gly Asp Pro His Gly Val Ser Met Phe Pro Asn Thr 225 230 235 240 Leu His Glu Asp Gln Val Arg Ser Asp Ala Ala Arg Glu Trp Leu Leu 245 250 255 Pro Asn Tyr Gln Arg Pro Asn Leu Gln Val Leu Thr Gly Gln Tyr Val 260 265 270 Gly Lys Val Leu Leu Ser Gln Asn Gly Thr Thr Pro Arg Ala Val Gly 275 280 285 Val Glu Phe Gly Thr His Lys Gly Asn Thr His Asn Val Tyr Ala Lys 290 295 300 His Glu Val Leu Leu Ala Ala Gly Ser Ala Val Ser Pro Thr Ile Leu 305 310 315 320 Glu Tyr Ser Gly Ile Gly Met Lys Ser Ile Leu Glu Pro Leu Gly Ile 325 330 335 Asp Thr Val Val Asp Leu Pro Val Gly Leu Asn Leu Gln Asp Gln Thr 340 345 350 Thr Ala Thr Val Arg Ser Arg Ile Thr Ser Ala Gly Ala Gly Gln Gly 355 360 365 Gln Ala Ala Trp Phe Ala Thr Phe Asn Glu Thr Phe Gly Asp Tyr Ser 370 375 380 Glu Lys Ala His Glu Leu Leu Asn Thr Lys Leu Glu Gln Trp Ala Glu 385 390 395 400 Glu Ala Val Ala Arg Gly Gly Phe His Asn Thr Thr Ala Leu Leu Ile 405 410 415 Gln Tyr Glu Asn Tyr Arg Asp Trp Ile Val Asn His Asn Val Ala Tyr 420 425 430 Ser Glu Leu Phe Leu Asp Thr Ala Gly Val Ala Ser Phe Asp Val Trp 435 440 445 Asp Leu Leu Pro Phe Thr Arg Gly Tyr Val His Ile Leu Asp Lys Asp 450 455 460 Pro Tyr Leu His His Phe Ala Tyr Asp Pro Gln Tyr Phe Leu Asn Glu 465 470 475 480 Leu Asp Leu Leu Gly Gln Ala Ala Ala Thr Gln Leu Ala Arg Asn Ile 485 490 495 Ser Asn Ser Gly Ala Met Gln Thr Tyr Phe Ala Gly Glu Thr Ile Pro 500 505 510 Gly Asp Asn Leu Ala Tyr Asp Ala Asp Leu Ser Ala Trp Thr Glu Tyr 515 520 525 Ile Pro Tyr His Phe Arg Pro Asn Tyr His Gly Val Gly Thr Cys Ser 530 535 540 Met Met Pro Lys Glu Met Gly Gly Val Val Asp Asn Ala Ala Arg Val 545 550 555 560 Tyr Gly Val Gln Gly Leu Arg Val Ile Asp Gly Ser Ile Pro Pro Thr 565 570 575 Gln Met Ser Ser His Val Met Thr Val Phe Tyr Ala Met Ala Leu Lys 580 585 590 Ile Ser Asp Ala Ile Leu Glu Asp Tyr Ala Ser Met Gln 595 600 605 <110> ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY <120> COSMETIC COMPOSITION FOR SKIN WHITENING COMPRISING LIGNIN PEROXIDASE AND DECOLORIZING METHOD OF MELANIN IN SKIN USING THE SAME <130> UTP19140KR <160> 2 <170> KoPatentIn 3.0 <210> 1 <211> 372 <212> PRT <213> Phanerochaete chrysosporium <220> <221> MISC_FEATURE <222> (1)..(372) <223> Lignin Peroxidase isozyme H8 <400> 1 Met Ala Phe Lys Gln Leu Phe Ala Ala Ile Ser Leu Ala Leu Leu Leu 1 5 10 15 Ser Ala Ala Asn Ala Ala Ala Val Ile Glu Lys Arg Ala Thr Cys Ser 20 25 30 Asn Gly Lys Thr Val Gly Asp Ala Ser Cys Cys Ala Trp Phe Asp Val 35 40 45 Leu Asp Asp Ile Gln Gln Asn Leu Phe His Gly Gly Gln Cys Gly Ala 50 55 60 Glu Ala His Glu Ser Ile Arg Leu Val Phe His Asp Ser Ile Ala Ile 65 70 75 80 Ser Pro Ala Met Glu Ala Gln Gly Lys Phe Gly Gly Gly Gly Ala Asp 85 90 95 Gly Ser Ile Met Ile Phe Asp Asp Ile Glu Thr Ala Phe His Pro Asn 100 105 110 Ile Gly Leu Asp Glu Ile Val Lys Leu Gln Lys Pro Phe Val Gln Lys 115 120 125 His Gly Val Thr Pro Gly Asp Phe Ile Ala Phe Ala Gly Arg Val Ala 130 135 140 Leu Ser Asn Cys Pro Gly Ala Pro Gln Met Asn Phe Phe Thr Gly Arg 145 150 155 160 Ala Pro Ala Thr Gln Pro Ala Pro Asp Gly Leu Val Pro Glu Pro Phe 165 170 175 His Thr Val Asp Gln Ile Ile Asn Arg Val Asn Asp Ala Gly Glu Phe 180 185 190 Asp Glu Leu Glu Leu Val Trp Met Leu Ser Ala His Ser Val Ala Ala 195 200 205 Val Asn Asp Val Asp Pro Thr Val Gln Gly Leu Pro Phe Asp Ser Thr 210 215 220 Pro Gly Ile Phe Asp Ser Gln Phe Phe Val Glu Thr Gln Leu Arg Gly 225 230 235 240 Thr Ala Phe Pro Gly Ser Gly Gly Asn Gln Gly Glu Val Glu Ser Pro 245 250 255 Leu Pro Gly Glu Ile Arg Ile Gln Ser Asp His Thr Ile Ala Arg Asp 260 265 270 Ser Arg Thr Ala Cys Glu Trp Gln Ser Phe Val Asn Asn Gln Ser Lys 275 280 285 Leu Val Asp Asp Phe Gln Phe Ile Phe Leu Ala Leu Thr Gln Leu Gly 290 295 300 Gln Asp Pro Asn Ala Met Thr Asp Cys Ser Asp Val Ile Pro Gln Ser 305 310 315 320 Lys Pro Ile Pro Gly Asn Leu Pro Phe Ser Phe Phe Pro Ala Gly Lys 325 330 335 Thr Ile Lys Asp Val Glu Gln Ala Cys Ala Glu Thr Pro Phe Pro Thr 340 345 350 Leu Thr Thr Leu Pro Gly Pro Glu Thr Ser Val Gln Arg Ile Pro Pro 355 360 365 Pro Pro Gly Ala 370 <210> 2 <211> 605 <212> PRT <213> Aspergillus niger <220> <221> MISC_FEATURE <222> (1)..(605) <223> Glucose Oxidase <400> 2 Met Gln Thr Leu Leu Val Ser Ser Leu Val Val Ser Leu Ala Ala Ala 1 5 10 15 Leu Pro His Tyr Ile Arg Ser Asn Gly Ile Glu Ala Ser Leu Leu Thr 20 25 30 Asp Pro Lys Asp Val Ser Gly Arg Thr Val Asp Tyr Ile Ile Ala Gly 35 40 45 Gly Gly Leu Thr Gly Leu Thr Thr Ala Ala Arg Leu Thr Glu Asn Pro 50 55 60 Asn Ile Ser Val Leu Val Ile Glu Ser Gly Ser Tyr Glu Ser Asp Arg 65 70 75 80 Gly Pro Ile Ile Glu Asp Leu Asn Ala Tyr Gly Asp Ile Phe Gly Ser 85 90 95 Ser Val Asp His Ala Tyr Glu Thr Val Glu Leu Ala Thr Asn Asn Gln 100 105 110 Thr Ala Leu Ile Arg Ser Gly Asn Gly Leu Gly Gly Ser Thr Leu Val 115 120 125 Asn Gly Gly Thr Trp Thr Arg Pro His Lys Ala Gln Val Asp Ser Trp 130 135 140 Glu Thr Val Phe Gly Asn Glu Gly Trp Asn Trp Asp Asn Val Ala Ala 145 150 155 160 Tyr Ser Leu Gln Ala Glu Arg Ala Arg Ala Pro Asn Ala Lys Gln Ile 165 170 175 Ala Ala Gly His Tyr Phe Asn Ala Ser Cys His Gly Val Asn Gly Thr 180 185 190 Val His Ala Gly Pro Arg Asp Thr Gly Asp Asp Tyr Ser Pro Ile Val 195 200 205 Lys Ala Leu Met Ser Ala Val Glu Asp Arg Gly Val Pro Thr Lys Lys 210 215 220 Asp Phe Gly Cys Gly Asp Pro His Gly Val Ser Met Phe Pro Asn Thr 225 230 235 240 Leu His Glu Asp Gln Val Arg Ser Asp Ala Ala Arg Glu Trp Leu Leu 245 250 255 Pro Asn Tyr Gln Arg Pro Asn Leu Gln Val Leu Thr Gly Gln Tyr Val 260 265 270 Gly Lys Val Leu Leu Ser Gln Asn Gly Thr Thr Pro Arg Ala Val Gly 275 280 285 Val Glu Phe Gly Thr His Lys Gly Asn Thr His Asn Val Tyr Ala Lys 290 295 300 His Glu Val Leu Leu Ala Ala Gly Ser Ala Val Ser Pro Thr Ile Leu 305 310 315 320 Glu Tyr Ser Gly Ile Gly Met Lys Ser Ile Leu Glu Pro Leu Gly Ile 325 330 335 Asp Thr Val Val Asp Leu Pro Val Gly Leu Asn Leu Gln Asp Gln Thr 340 345 350 Thr Ala Thr Val Arg Ser Arg Ile Thr Ser Ala Gly Ala Gly Gln Gly 355 360 365 Gln Ala Ala Trp Phe Ala Thr Phe Asn Glu Thr Phe Gly Asp Tyr Ser 370 375 380 Glu Lys Ala His Glu Leu Leu Asn Thr Lys Leu Glu Gln Trp Ala Glu 385 390 395 400 Glu Ala Val Ala Arg Gly Gly Phe His Asn Thr Thr Ala Leu Leu Ile 405 410 415 Gln Tyr Glu Asn Tyr Arg Asp Trp Ile Val Asn His Asn Val Ala Tyr 420 425 430 Ser Glu Leu Phe Leu Asp Thr Ala Gly Val Ala Ser Phe Asp Val Trp 435 440 445 Asp Leu Leu Pro Phe Thr Arg Gly Tyr Val His Ile Leu Asp Lys Asp 450 455 460 Pro Tyr Leu His His Phe Ala Tyr Asp Pro Gln Tyr Phe Leu Asn Glu 465 470 475 480 Leu Asp Leu Leu Gly Gln Ala Ala Ala Thr Gln Leu Ala Arg Asn Ile 485 490 495 Ser Asn Ser Gly Ala Met Gln Thr Tyr Phe Ala Gly Glu Thr Ile Pro 500 505 510 Gly Asp Asn Leu Ala Tyr Asp Ala Asp Leu Ser Ala Trp Thr Glu Tyr 515 520 525 Ile Pro Tyr His Phe Arg Pro Asn Tyr His Gly Val Gly Thr Cys Ser 530 535 540 Met Met Pro Lys Glu Met Gly Gly Val Val Asp Asn Ala Ala Arg Val 545 550 555 560 Tyr Gly Val Gln Gly Leu Arg Val Ile Asp Gly Ser Ile Pro Pro Thr 565 570 575 Gln Met Ser Ser His Val Met Thr Val Phe Tyr Ala Met Ala Leu Lys 580 585 590 Ile Ser Asp Ala Ile Leu Glu Asp Tyr Ala Ser Met Gln 595 600 605
Claims (16)
상기 조성물의 pH는 3.9 내지 4.1인, 피부 미백용 화장료 조성물.As a cosmetic composition for skin whitening comprising lignin peroxidase consisting of the amino acid sequence of SEQ ID NO: 1,
The pH of the composition is 3.9 to 4.1, a cosmetic composition for skin whitening.
상기 적용은 pH 3.9 내지 4.1의 조건에서 이루어지는 것인, 피부 내 멜라닌의 탈색을 통한 미용 방법.A cosmetic method through depigmentation of melanin in the skin comprising the step of applying lignin peroxidase consisting of the amino acid sequence of SEQ ID NO: 1 to the skin of an individual, veratrile alcohol, and hydrogen peroxide,
The application is made under the conditions of pH 3.9 to 4.1, a cosmetic method through decolorization of melanin in the skin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190060228A KR102223091B1 (en) | 2019-05-22 | 2019-05-22 | Cosmetic composition for skin whitening comprising lignin peroxidase and decolorizing method of melanin in skin using the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190060228A KR102223091B1 (en) | 2019-05-22 | 2019-05-22 | Cosmetic composition for skin whitening comprising lignin peroxidase and decolorizing method of melanin in skin using the same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20200134585A KR20200134585A (en) | 2020-12-02 |
KR102223091B1 true KR102223091B1 (en) | 2021-03-04 |
Family
ID=73791792
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190060228A Active KR102223091B1 (en) | 2019-05-22 | 2019-05-22 | Cosmetic composition for skin whitening comprising lignin peroxidase and decolorizing method of melanin in skin using the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102223091B1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102686222B1 (en) | 2020-10-16 | 2024-07-17 | 주식회사 엘지에너지솔루션 | Battery pack and vehicle comprising the same |
KR102677568B1 (en) * | 2021-08-13 | 2024-06-21 | 울산과학기술원 | Costmetic composition for skin whitening comprising lignin peroxidase isozyme and use thereof |
EP4468864A1 (en) * | 2022-01-25 | 2024-12-04 | Ventana Medical Systems, Inc. | Materials and methods for bleaching melanin-pigmented tissues |
KR102681874B1 (en) * | 2022-12-14 | 2024-07-05 | 울산과학기술원 | Manufacturing method of lignin peroxidase using microorganisms |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102009045798A1 (en) | 2009-10-19 | 2010-08-05 | Henkel Ag & Co. Kgaa | Cosmetic agent, useful for lightening e.g. skin, comprises peroxidase and substrate for hydrogen peroxide producing enzyme in a first container, and hydrogen peroxide producing enzyme and substrate for the peroxidase in a second container |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101168741B1 (en) * | 2002-12-12 | 2012-07-27 | 알.비.티 (라쿠토 바이오 테크놀로지스) 리미티드 | Methods of producing lignin peroxidase and its use in skin and hair lightening |
CA2912997C (en) * | 2013-05-27 | 2021-09-07 | Rakuto Bio Technologies Ltd. | Enzymatic system-containing cosmetic compositions |
-
2019
- 2019-05-22 KR KR1020190060228A patent/KR102223091B1/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102009045798A1 (en) | 2009-10-19 | 2010-08-05 | Henkel Ag & Co. Kgaa | Cosmetic agent, useful for lightening e.g. skin, comprises peroxidase and substrate for hydrogen peroxide producing enzyme in a first container, and hydrogen peroxide producing enzyme and substrate for the peroxidase in a second container |
Non-Patent Citations (2)
Title |
---|
Biotechnology for Biofuels volume 11, Article number: 325 (2018) |
Textile Research Journal, (2000) 70, pp.409-414 |
Also Published As
Publication number | Publication date |
---|---|
KR20200134585A (en) | 2020-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102223091B1 (en) | Cosmetic composition for skin whitening comprising lignin peroxidase and decolorizing method of melanin in skin using the same | |
CN101316576B (en) | A composition comprising a coupled enzyme system | |
CN109414398B (en) | Antioxidant composition for skin | |
KR101040507B1 (en) | Cosmetic composition for preventing photoaging and improving skin wrinkles containing extract of Magnolia sieboldii | |
KR101724526B1 (en) | Cosmetic Composition Containing Fermentative Extract of Chenopodium quinoa Willd as Active Ingredient | |
JP6348890B2 (en) | Decomposition inhibitor, anti-aging agent and topical skin preparation | |
KR20210036803A (en) | Cosmetic composition for preventing skin aging and improving skin winkle comprising extracts of Selaginella rossii | |
US11185494B2 (en) | Skin whitening composition comprising culture of pseudoalteromonas carrageenovora or extract thereof | |
KR102710032B1 (en) | Cosmetic composition for antioxidation, skin-whitening and anti-wrinkle comprising rice by-product extracts fermented by lactic acid bacteria | |
KR20180045298A (en) | Cosmetic composition for preventing photo-aging comprising agastache rugosa extract | |
KR20210046195A (en) | Cosmetic composition for improving skin wrinkle comprising extract of clematic florida flower | |
KR102677568B1 (en) | Costmetic composition for skin whitening comprising lignin peroxidase isozyme and use thereof | |
KR102249252B1 (en) | A cosmetic composition comprising microalgae-derived peptide | |
US11376212B2 (en) | Skin whitening composition comprising cultured product of Bacillus hwajinpoensis or extract thereof | |
KR102038697B1 (en) | Cosmetic Composition for Anti-oxidation and Whitening of Skin | |
JPH083018A (en) | Cosmetic for skin aging prevention | |
KR20210067567A (en) | Cosmetic composition for improving skin wrinkle comprising extract of plumeria alba flower and lilium concolor var | |
KR102814373B1 (en) | Cosmetic composition for antioxidant or whitening containing Eckmaxol as an active ingredient | |
KR102062311B1 (en) | Method for Producing Agaricus Blazei Extract, Extract and Cosmetic Composition Using the Same | |
US11173108B2 (en) | Skin whitening composition comprising cultured product of pseudoalteromonas peptidolytica or extract thereof | |
FR2813529A1 (en) | Topical compositions, used to protect against heavy metals and ultraviolet radiation, contain metallothionein proteins | |
KR20250001338A (en) | Composition for Anti-Inflammation and Anti-Wrinkle Comprising Extract of Enzyme-Treated Calendula officinalis as Active Ingredient | |
WO2023196762A1 (en) | Cosmetic compositions for skin health and methods of using same | |
HK40002870A (en) | Antioxidant composition for skin | |
JPH0725744A (en) | Fair-skinning cosmetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20190522 |
|
PA0201 | Request for examination | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20200827 Patent event code: PE09021S01D |
|
PG1501 | Laying open of application | ||
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20210219 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20210225 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20210226 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration |